These terms and conditions govern your use of the website alphaminr.com and its related services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr, (“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms include the provisions in this document as well as those in the Privacy Policy. These terms may be modified at any time.
Your subscription will be on a month to month basis and automatically renew every month. You may terminate your subscription at any time through your account.
We will provide you with advance notice of any change in fees.
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The service is provided “As is”. The materials and information accessible through the Service are solely for informational purposes. While we strive to provide good information and data, we make no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR (2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision shall not affect the validity or enforceability of the remaining provisions herein.
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal information when we provide our service (“Service”). This Privacy Policy explains how information is collected about you either directly or indirectly. By using our service, you acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy Policy, please do not use our Service. You should contact us if you have questions about it. We may modify this Privacy Policy periodically.
When you register for our Service, we collect information from you such as your name, email address and credit card information.
Like many other websites we use “cookies”, which are small text files that are stored on your computer or other device that record your preferences and actions, including how you use the website. You can set your browser or device to refuse all cookies or to alert you when a cookie is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not function properly. We collect information when you use our Service. This includes which pages you visit.
We use Google Analytics and we use Stripe for payment processing. We will not share the information we collect with third parties for promotional purposes. We may share personal information with law enforcement as required or permitted by law.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(Mark One)
|
|
|
x
|
ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
|
|
o
|
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
|
Delaware
|
|
|
|
75-1618004
|
|
(State or other jurisdiction of incorporation or organization)
|
|
|
|
(IRS Employer Identification No.)
|
|
8000 S. Federal Way, Boise, Idaho
|
|
|
|
83716-9632
|
|
(Address of principal executive offices)
|
|
|
|
(Zip Code)
|
|
Registrant's telephone number, including area code
|
|
|
|
(208) 368-4000
|
|
Securities registered pursuant to Section 12(b) of the Act:
|
||||
|
Title of each class
|
|
Trading Symbol
|
|
Name of each exchange on which registered
|
|
Common Stock, par value $0.10 per share
|
|
MU
|
|
NASDAQ Global Select Market
|
|
Large Accelerated Filer
x
|
Accelerated Filer
o
|
Non-Accelerated Filer
o
|
Smaller Reporting Company
o
|
Emerging Growth Company
o
|
|
|
|
|
|
|
|
Term
|
|
Definition
|
|
Term
|
|
Definition
|
|
2022 Term Loan B
|
|
Senior Secured Term Loan B due 2022
|
|
Micron
|
|
Micron Technology, Inc. (Parent Company)
|
|
2024 Notes
|
|
5.25% Senior Notes due 2024
|
|
MMJ
|
|
Micron Memory Japan, Inc.
|
|
2025 Notes
|
|
5.50% Senior Notes due 2025
|
|
MMJ Companies
|
|
MAI and MMJ
|
|
2026 Notes
|
|
5.63% Senior Notes due 2026
|
|
MMJ Group
|
|
MMJ and its subsidiaries
|
|
2027 Notes
|
|
4.19% Senior Notes due 2027
|
|
MMT
|
|
Micron Memory Taiwan Co., Ltd.
|
|
2029 Notes
|
|
5.33% Senior Notes due 2029
|
|
MSP
|
|
Micron Semiconductor Products, Inc.
|
|
2030 Notes
|
|
4.66% Senior Notes due 2027
|
|
MSTW
|
|
Micron Semiconductor Taiwan Co., Ltd.
|
|
2032D Notes
|
|
3.13% Convertible Senior Notes due 2032
|
|
MTTW
|
|
Micron Technology Taiwan, Inc.
|
|
2033F Notes
|
|
2.13% Convertible Senior Notes due 2033
|
|
NAND
|
|
Not And
|
|
2043G Notes
|
|
3.00% Convertible Senior Notes due 2043
|
|
Nanya
|
|
Nanya Technology Corporation
|
|
ASIC
|
|
Application-Specific Integrated Circuit
|
|
NOR
|
|
Not Or
|
|
CuA
|
|
CMOS Under the Array
|
|
NVMe
|
|
Non-Volatile Memory Express
|
|
DDR
|
|
Double Data Rate
|
|
OEM
|
|
Original Equipment Manufacturer
|
|
DRAM
|
|
Dynamic Random Access Memory
|
|
PCIe
|
|
Peripheral Component Interconnect Express
|
|
e.MMC
|
|
Embedded Multi-Media Controller
|
|
Qimonda
|
|
Qimonda AG
|
|
eMCP
|
|
An e.MMC or UFS solution with LPDRAM in the same package
|
|
QLC
|
|
Quad-Level Cell (four bits per cell)
|
|
GDDR
|
|
Graphics Double Data Rate
|
|
RDIMM
|
|
Registered Dual In-line Memory Module
|
|
HDD
|
|
Hard Disk Drive
|
|
SATA
|
|
Serial AT Attachment
|
|
IMFT
|
|
IM Flash Technologies, LLC
|
|
SLC
|
|
Single-Level Cell (one bit per cell)
|
|
Inotera
|
|
Inotera Memories, Inc.
|
|
SSD
|
|
Solid State Drive
|
|
Intel
|
|
Intel Corporation
|
|
TLC
|
|
Triple-Level Cell (three bits per cell)
|
|
LPDDR
|
|
Low Power Double Data Rate
|
|
UFS
|
|
Universal Flash Storage
|
|
MAI
|
|
Micron Akita, Inc.
|
|
uMCP
|
|
UFS-based MCP
|
|
MCP
|
|
Multi-Chip Package
|
|
VIE
|
|
Variable Interest Entity
|
|
Name
|
|
Age
|
|
Officer/ Director Since
|
|
Position
|
|
April S. Arnzen
|
|
48
|
|
2015
|
|
Senior Vice President, Human Resources
|
|
Michael W. Bokan
|
|
58
|
|
2019
|
|
Senior Vice President, Worldwide Sales
|
|
Manish Bhatia
|
|
47
|
|
2018
|
|
Executive Vice President, Global Operations
|
|
Scott J. DeBoer
|
|
53
|
|
2007
|
|
Executive Vice President, Technology Development
|
|
Sanjay Mehrotra
|
|
61
|
|
2017
|
|
President and Chief Executive Officer, Director
|
|
Joel L. Poppen
|
|
55
|
|
2013
|
|
Senior Vice President, Legal Affairs, General Counsel, and Corporate Secretary
|
|
Sumit Sadana
|
|
50
|
|
2017
|
|
Executive Vice President and Chief Business Officer
|
|
David A. Zinsner
|
|
50
|
|
2018
|
|
Senior Vice President and Chief Financial Officer
|
|
Robert L. Bailey
|
|
62
|
|
2007
|
|
Director
|
|
Richard M. Beyer
|
|
70
|
|
2013
|
|
Director
|
|
Patrick J. Byrne
|
|
58
|
|
2011
|
|
Director
|
|
Steven J. Gomo
|
|
67
|
|
2019
|
|
Director
|
|
Mary Pat McCarthy
|
|
64
|
|
2019
|
|
Director
|
|
Robert E. Switz
|
|
72
|
|
2006
|
|
Chairman of the Board of Directors
|
|
MaryAnn Wright
|
|
57
|
|
2019
|
|
Director
|
|
|
|
DRAM
|
|
NAND
|
||
|
|
|
|
|
|
||
|
|
|
(percentage change in average selling prices)
|
||||
|
2019 from 2018
|
|
(30
|
)%
|
|
(44
|
)%
|
|
2018 from 2017
|
|
37
|
%
|
|
(8
|
)%
|
|
2017 from 2016
|
|
19
|
%
|
|
(7
|
)%
|
|
2016 from 2015
|
|
(35
|
)%
|
|
(19
|
)%
|
|
2015 from 2014
|
|
(11
|
)%
|
|
(15
|
)%
|
|
•
|
that we will be successful in developing competitive
new semiconductor memory and storage technologies;
|
|
•
|
that we will be able to cost-effectively manufacture new products;
|
|
•
|
that we will be able to successfully market these technologies; and
|
|
•
|
that margins generated from sales of these products will allow us to recover costs of development efforts.
|
|
•
|
export and import duties, changes to import and export regulations, customs regulations and processes, and restrictions on the transfer of funds;
|
|
•
|
imposition of bans on sales of goods or services to one or more of our significant foreign customers;
|
|
•
|
compliance with U.S. and international laws involving international operations, including the Foreign Corrupt Practices Act of 1977, as amended, export and import laws, and similar rules and regulations;
|
|
•
|
theft of intellectual property;
|
|
•
|
political and economic instability;
|
|
•
|
government actions or civil unrest preventing the flow of products, including delays in shipping and obtaining products, cancellation of orders, or loss or damage of products;
|
|
•
|
problems with the transportation or delivery of products;
|
|
•
|
issues arising from cultural or language differences and labor unrest;
|
|
•
|
longer payment cycles and greater difficulty in collecting accounts receivable;
|
|
•
|
compliance with trade, technical standards, and other laws in a variety of jurisdictions;
|
|
•
|
contractual and regulatory limitations on the ability to maintain flexibility with staffing levels;
|
|
•
|
disruptions to manufacturing operations as a result of actions imposed by foreign governments;
|
|
•
|
changes in economic policies of foreign governments; and
|
|
•
|
difficulties in staffing and managing international operations.
|
|
•
|
that our product development efforts will be successful;
|
|
•
|
that we will be able to cost-effectively manufacture new products;
|
|
•
|
that we will be able to successfully market these products;
|
|
•
|
that we will be able to establish or maintain key relationships with customers, or that we will not be prohibited from working with certain customers, for specific chip set or design requirements;
|
|
•
|
that we will be able to introduce new products into the market and qualify them with our customers on a timely basis; or
|
|
•
|
we may be required or agree to compensate customers for costs incurred or damages caused by defective or incompatible products and to replace products;
|
|
•
|
we could incur a decrease in revenue or adjustment to pricing commensurate with the reimbursement of such costs or alleged damages; and
|
|
•
|
we may encounter adverse publicity, which could cause a decrease in sales of our products or harm our relationships with existing or potential customers.
|
|
•
|
pay significant monetary damages, fines, royalties, or penalties;
|
|
•
|
enter into license or settlement agreements covering such intellectual property rights;
|
|
•
|
make material changes to or redesign our products and/or manufacturing processes; and/or
|
|
•
|
cease manufacturing, having made, selling, offering for sale, importing, marketing, or using products and/or manufacturing processes in certain jurisdictions.
|
|
◦
|
ongoing or future development, manufacturing, or operational activities;
|
|
◦
|
the amount, timing, or nature of further investments; and
|
|
◦
|
commercial terms in our joint ventures or strategic relationships;
|
|
•
|
differences in participation on funding capital investments in our joint ventures due to differing business models or long-term business goals;
|
|
•
|
disputes with partners regarding the terms of arrangements, including the termination or discontinuance of our joint ventures, or that terms of such arrangements are unfavorable; and
|
|
•
|
require us to use a large portion of our cash flow to pay principal and interest on debt, which will reduce the amount of cash flow available to fund working capital, capital expenditures, acquisitions, R&D expenditures, and other business activities;
|
|
•
|
require us to use cash and/or issue shares of our common stock to settle any conversion obligations of our convertible notes;
|
|
•
|
result in certain of our debt instruments being accelerated to be immediately due and payable or being deemed to be in default if certain terms of default are triggered, such as applicable cross payment default and/or cross-acceleration provisions;
|
|
•
|
adversely impact our credit rating, which could increase future borrowing costs;
|
|
•
|
limit our future ability to raise funds for capital expenditures, strategic acquisitions or business opportunities, R&D, and other general corporate requirements;
|
|
•
|
restrict our ability to incur specified indebtedness, create or incur certain liens, and enter into sale-leaseback financing transactions;
|
|
•
|
increase our vulnerability to adverse economic and semiconductor memory and storage industry conditions;
|
|
•
|
increase our exposure to interest rate risk from variable rate indebtedness;
|
|
•
|
continue to dilute our earnings per share as a result of the conversion provisions in our convertible notes; and
|
|
•
|
require us to continue to pay cash amounts substantially in excess of the principal amounts upon settlement of our convertible notes to minimize dilution of our earnings per share.
|
|
•
|
integrating the operations, technologies, and products of acquired or newly formed entities into our operations;
|
|
•
|
increasing capital expenditures to upgrade and maintain facilities;
|
|
•
|
increased debt levels;
|
|
•
|
the assumption of unknown or underestimated liabilities;
|
|
•
|
the use of cash to finance a transaction, which may reduce the availability of cash to fund working capital, capital expenditures, R&D expenditures, and other business activities;
|
|
•
|
diverting management's attention from daily operations;
|
|
•
|
managing larger or more complex operations and facilities and employees in separate and diverse geographic areas;
|
|
•
|
hiring and retaining key employees;
|
|
•
|
requirements imposed by governmental authorities in connection with the regulatory review of a transaction, which may include, among other things, divestitures or restrictions on the conduct of our business or the acquired business;
|
|
•
|
inability to realize synergies or other expected benefits;
|
|
•
|
failure to maintain customer, vendor, and other relationships;
|
|
•
|
inadequacy or ineffectiveness of an acquired company's internal financial controls, disclosure controls and procedures, compliance programs, and/or environmental, health and safety, anti-corruption, human resource, or other policies or practices; and
|
|
•
|
impairment of acquired intangible assets, goodwill, or other assets as a result of changing business conditions, technological advancements, or worse-than-expected performance of the acquired business.
|
|
•
|
suspension of production;
|
|
•
|
remediation costs;
|
|
•
|
alteration of our manufacturing processes;
|
|
•
|
regulatory penalties, fines, and legal liabilities; and
|
|
•
|
reputational challenges.
|
|
Location
|
|
Principal Operations
|
|
Taiwan
|
|
R&D, wafer fabrication, component assembly and test, module assembly and test
|
|
Singapore
|
|
R&D, wafer fabrication, component assembly and test, module assembly and test
|
|
Japan
|
|
R&D, wafer fabrication
|
|
United States
|
|
R&D, wafer fabrication, reticle manufacturing
|
|
China
|
|
Component assembly and test, module assembly and test
|
|
Malaysia
|
|
Component assembly and test, module assembly and test
|
|
Period
|
|
(a) Total number of shares purchased
|
|
(b) Average price paid per share
|
|
(c) Total number of shares (or units) purchased as part of publicly announced plans or programs
|
|
(d) Maximum number (or approximate dollar value) of shares (or units) that may yet be purchased under publicly announced plans or programs
|
||||||||
|
May 31, 2019
|
–
|
July 4, 2019
|
|
—
|
|
|
$
|
—
|
|
|
—
|
|
|
|
||
|
July 5, 2019
|
–
|
August 1, 2019
|
|
—
|
|
|
—
|
|
|
—
|
|
|
|
|||
|
August 2, 2019
|
–
|
August 29, 2019
|
|
—
|
|
|
—
|
|
|
—
|
|
|
|
|||
|
|
|
|
|
—
|
|
|
|
|
|
|
$
|
7,337,838,234
|
|
|||
|
|
|
2014
|
|
2015
|
|
2016
|
|
2017
|
|
2018
|
|
2019
|
||||||||||||
|
Micron Technology, Inc.
|
|
$
|
100
|
|
|
$
|
50
|
|
|
$
|
51
|
|
|
$
|
98
|
|
|
$
|
161
|
|
|
$
|
139
|
|
|
S&P 500 Composite Index
|
|
100
|
|
|
100
|
|
|
113
|
|
|
131
|
|
|
157
|
|
|
162
|
|
||||||
|
Philadelphia Semiconductor Index (SOX)
|
|
100
|
|
|
97
|
|
|
130
|
|
|
184
|
|
|
235
|
|
|
257
|
|
||||||
|
|
|
2019
|
|
2018
|
|
2017
|
|
2016
|
|
2015
|
||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||
|
|
|
(in millions, except per share amounts)
|
||||||||||||||||||
|
Revenue
|
|
$
|
23,406
|
|
|
$
|
30,391
|
|
|
$
|
20,322
|
|
|
$
|
12,399
|
|
|
$
|
16,192
|
|
|
Gross margin
|
|
10,702
|
|
|
17,891
|
|
|
8,436
|
|
|
2,505
|
|
|
5,215
|
|
|||||
|
Operating income
|
|
7,376
|
|
|
14,994
|
|
|
5,868
|
|
|
168
|
|
|
2,998
|
|
|||||
|
Net income (loss)
|
|
6,358
|
|
|
14,138
|
|
|
5,090
|
|
|
(275
|
)
|
|
2,899
|
|
|||||
|
Net income (loss) attributable to Micron
|
|
6,313
|
|
|
14,135
|
|
|
5,089
|
|
|
(276
|
)
|
|
2,899
|
|
|||||
|
Diluted earnings (loss) per share
|
|
5.51
|
|
|
11.51
|
|
|
4.41
|
|
|
(0.27
|
)
|
|
2.47
|
|
|||||
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||
|
Cash and short-term investments
|
|
7,955
|
|
|
6,802
|
|
|
5,428
|
|
|
4,398
|
|
|
3,521
|
|
|||||
|
Total current assets
|
|
16,503
|
|
|
16,039
|
|
|
12,457
|
|
|
9,495
|
|
|
8,596
|
|
|||||
|
Property, plant, and equipment
|
|
28,240
|
|
|
23,672
|
|
|
19,431
|
|
|
14,686
|
|
|
10,554
|
|
|||||
|
Total assets
|
|
48,887
|
|
|
43,376
|
|
|
35,336
|
|
|
27,540
|
|
|
24,143
|
|
|||||
|
Total current liabilities
|
|
6,390
|
|
|
5,754
|
|
|
5,334
|
|
|
4,835
|
|
|
3,905
|
|
|||||
|
Long-term debt
|
|
4,541
|
|
|
3,777
|
|
|
9,872
|
|
|
9,154
|
|
|
6,252
|
|
|||||
|
Total Micron shareholders' equity
|
|
35,881
|
|
|
32,294
|
|
|
18,621
|
|
|
12,080
|
|
|
12,302
|
|
|||||
|
Noncontrolling interests in subsidiaries
|
|
889
|
|
|
870
|
|
|
849
|
|
|
848
|
|
|
937
|
|
|||||
|
Total equity
|
|
36,770
|
|
|
33,164
|
|
|
19,470
|
|
|
12,928
|
|
|
13,239
|
|
|||||
|
For the year ended
|
|
2019
|
|
2018
|
|
2017
|
|||||||||||||||
|
Revenue
|
|
$
|
23,406
|
|
|
100
|
%
|
|
$
|
30,391
|
|
|
100
|
%
|
|
$
|
20,322
|
|
|
100
|
%
|
|
Cost of goods sold
|
|
12,704
|
|
|
54
|
%
|
|
12,500
|
|
|
41
|
%
|
|
11,886
|
|
|
58
|
%
|
|||
|
Gross margin
|
|
10,702
|
|
|
46
|
%
|
|
17,891
|
|
|
59
|
%
|
|
8,436
|
|
|
42
|
%
|
|||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||
|
Selling, general, and administrative
|
|
836
|
|
|
4
|
%
|
|
813
|
|
|
3
|
%
|
|
743
|
|
|
4
|
%
|
|||
|
Research and development
|
|
2,441
|
|
|
10
|
%
|
|
2,141
|
|
|
7
|
%
|
|
1,824
|
|
|
9
|
%
|
|||
|
Other operating (income) expense, net
|
|
49
|
|
|
—
|
%
|
|
(57
|
)
|
|
—
|
%
|
|
1
|
|
|
—
|
%
|
|||
|
Operating income
|
|
7,376
|
|
|
32
|
%
|
|
14,994
|
|
|
49
|
%
|
|
5,868
|
|
|
29
|
%
|
|||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||
|
Interest income (expense), net
|
|
77
|
|
|
—
|
%
|
|
(222
|
)
|
|
(1
|
)%
|
|
(560
|
)
|
|
(3
|
)%
|
|||
|
Other non-operating income (expense), net
|
|
(405
|
)
|
|
(2
|
)%
|
|
(465
|
)
|
|
(2
|
)%
|
|
(112
|
)
|
|
(1
|
)%
|
|||
|
Income tax (provision) benefit
|
|
(693
|
)
|
|
(3
|
)%
|
|
(168
|
)
|
|
(1
|
)%
|
|
(114
|
)
|
|
(1
|
)%
|
|||
|
Equity in net income (loss) of equity method investees
|
|
3
|
|
|
—
|
%
|
|
(1
|
)
|
|
—
|
%
|
|
8
|
|
|
—
|
%
|
|||
|
Net income attributable to noncontrolling interests
|
|
(45
|
)
|
|
—
|
%
|
|
(3
|
)
|
|
—
|
%
|
|
(1
|
)
|
|
—
|
%
|
|||
|
Net income attributable to Micron
|
|
$
|
6,313
|
|
|
27
|
%
|
|
$
|
14,135
|
|
|
47
|
%
|
|
$
|
5,089
|
|
|
25
|
%
|
|
For the year ended
|
|
2019
|
|
2018
|
|
2017
|
|||||||||||||||
|
CNBU
|
|
$
|
9,968
|
|
|
43
|
%
|
|
$
|
15,252
|
|
|
50
|
%
|
|
$
|
8,624
|
|
|
42
|
%
|
|
MBU
|
|
6,403
|
|
|
27
|
%
|
|
6,579
|
|
|
22
|
%
|
|
4,424
|
|
|
22
|
%
|
|||
|
SBU
|
|
3,826
|
|
|
16
|
%
|
|
5,022
|
|
|
17
|
%
|
|
4,514
|
|
|
22
|
%
|
|||
|
EBU
|
|
3,137
|
|
|
13
|
%
|
|
3,479
|
|
|
11
|
%
|
|
2,695
|
|
|
13
|
%
|
|||
|
All Other
|
|
72
|
|
|
—
|
%
|
|
59
|
|
|
—
|
%
|
|
65
|
|
|
—
|
%
|
|||
|
|
|
$
|
23,406
|
|
|
|
|
$
|
30,391
|
|
|
|
|
|
$
|
20,322
|
|
|
|
|
|
|
For the year ended
|
|
2019
|
|
2018
|
|
2017
|
|||||||||||||||
|
CNBU
|
|
$
|
4,645
|
|
|
47
|
%
|
|
$
|
9,773
|
|
|
64
|
%
|
|
$
|
3,755
|
|
|
44
|
%
|
|
MBU
|
|
2,606
|
|
|
41
|
%
|
|
3,033
|
|
|
46
|
%
|
|
927
|
|
|
21
|
%
|
|||
|
SBU
|
|
(386
|
)
|
|
(10
|
)%
|
|
964
|
|
|
19
|
%
|
|
552
|
|
|
12
|
%
|
|||
|
EBU
|
|
923
|
|
|
29
|
%
|
|
1,473
|
|
|
42
|
%
|
|
975
|
|
|
36
|
%
|
|||
|
All Other
|
|
13
|
|
|
18
|
%
|
|
—
|
|
|
—
|
%
|
|
23
|
|
|
35
|
%
|
|||
|
|
|
$
|
7,801
|
|
|
|
|
$
|
15,243
|
|
|
|
|
$
|
6,232
|
|
|
|
|||
|
For the year ended
|
|
2019
|
|
2018
|
|
2017
|
||||||
|
Income tax (provision) benefit, excluding items below
|
|
$
|
(530
|
)
|
|
$
|
(274
|
)
|
|
$
|
(168
|
)
|
|
Utilization of and other changes in net deferred tax assets of MMJ, MMT, and MTTW
|
|
(173
|
)
|
|
(68
|
)
|
|
54
|
|
|||
|
Repatriation Tax, net of adjustments related to uncertain tax positions
|
|
10
|
|
|
(1,030
|
)
|
|
—
|
|
|||
|
Release of the valuation allowance on net deferred tax assets of our U.S. operations
|
|
—
|
|
|
1,337
|
|
|
—
|
|
|||
|
Remeasurement of deferred tax assets and liabilities reflecting lower U.S. corporate tax rates
|
|
—
|
|
|
(133
|
)
|
|
—
|
|
|||
|
|
|
$
|
(693
|
)
|
|
$
|
(168
|
)
|
|
$
|
(114
|
)
|
|
|
|
|
|
|
|
|
||||||
|
Effective tax rate
|
|
9.8
|
%
|
|
1.2
|
%
|
|
2.2
|
%
|
|||
|
•
|
Equity Plans
|
|
•
|
Research and Development
|
|
•
|
Other Operating Income (Expense), Net
|
|
•
|
Other Non-Operating Income (Expense), Net
|
|
For the year ended
|
|
2019
|
|
2018
|
|
2017
|
||||||
|
Net cash provided by operating activities
|
|
$
|
13,189
|
|
|
$
|
17,400
|
|
|
$
|
8,153
|
|
|
Net cash provided by (used for) investing activities
|
|
(10,085
|
)
|
|
(8,216
|
)
|
|
(7,537
|
)
|
|||
|
Net cash provided by (used for) financing activities
|
|
(2,438
|
)
|
|
(7,776
|
)
|
|
349
|
|
|||
|
Effect of changes in currency exchange rates on cash, cash equivalents, and restricted cash
|
|
26
|
|
|
(37
|
)
|
|
(12
|
)
|
|||
|
Net increase in cash, cash equivalents, and restricted cash
|
|
$
|
692
|
|
|
$
|
1,371
|
|
|
$
|
953
|
|
|
|
|
Settlement Option
|
|
|
|
If Settled With Minimum Cash Required
|
|
If Settled Entirely With Cash
|
||||||||||
|
|
|
Principal Amount
|
|
Amount in Excess of Principal
|
|
Underlying Shares
|
|
Cash
|
|
Remainder in Shares
|
|
|||||||
|
2032D Notes
|
|
Cash and/or shares
|
|
Cash and/or shares
|
|
13
|
|
|
$
|
—
|
|
|
13
|
|
|
$
|
598
|
|
|
2033F Notes
|
|
Cash
|
|
Cash and/or shares
|
|
6
|
|
|
197
|
|
|
1
|
|
|
252
|
|
||
|
|
|
|
|
|
|
19
|
|
|
$
|
197
|
|
|
14
|
|
|
$
|
850
|
|
|
|
|
Payments Due by Period
|
||||||||||||||||||
|
As of August 29, 2019
|
|
Total
|
|
Less than 1 year
|
|
1-3 years
|
|
|
3-5 years
|
|
|
More than 5 years
|
||||||||
|
Notes payable
(1)(2)
|
|
$
|
6,811
|
|
|
$
|
1,302
|
|
|
$
|
530
|
|
|
$
|
978
|
|
|
$
|
4,001
|
|
|
Capital lease obligations
(2)
|
|
702
|
|
|
248
|
|
|
180
|
|
|
85
|
|
|
189
|
|
|||||
|
Operating leases
(3)
|
|
752
|
|
|
54
|
|
|
127
|
|
|
112
|
|
|
459
|
|
|||||
|
Purchase obligations
(4)
|
|
7,575
|
|
|
5,155
|
|
|
1,997
|
|
|
67
|
|
|
356
|
|
|||||
|
Other long-term liabilities
(5)
|
|
325
|
|
|
190
|
|
|
109
|
|
|
9
|
|
|
17
|
|
|||||
|
Total
|
|
$
|
16,165
|
|
|
$
|
6,949
|
|
|
$
|
2,943
|
|
|
$
|
1,251
|
|
|
$
|
5,022
|
|
|
(1)
|
Amounts include MMJ Creditor Payments, convertible notes, and other notes.
|
|
(2)
|
Amounts include principal and interest.
|
|
(3)
|
Amounts include contractually obligated minimum lease payments for operating leases having an initial noncancelable term in excess of one year.
|
|
(4)
|
Purchase obligations include all commitments to purchase goods or services of either a fixed or minimum quantity that meet any of the following criteria: (1) they are noncancelable, (2) we would incur a penalty if the agreement was canceled, or (3) we must make specified minimum payments even if we do not take delivery of the contracted products or services. If the obligation to purchase goods or services is noncancelable, the entire value of the contract was included in the above table. If the obligation is cancelable, but we would incur a penalty if canceled, only the dollar amount of the penalty was included as a purchase obligation. Contracted minimum amounts specified in any take-or-pay contracts were included in the above table as they represent the portion of each contract that is a firm commitment.
|
|
(5)
|
Amounts represent future cash payments to satisfy other long-term liabilities recorded on our consolidated balance sheet, including $190 million for the current portion of these long-term liabilities. We are unable to reliably estimate the timing of future certain payments related to uncertain tax positions and deferred tax liabilities; therefore, the amount has been excluded from the preceding table. However, other noncurrent liabilities recorded on our consolidated balance sheet included these uncertain tax positions and deferred tax liabilities.
|
|
•
|
Debt, including discount rate and timing of payments;
|
|
•
|
Deferred tax assets, including projections of future taxable income and tax rates;
|
|
•
|
Fair value of consideration paid or transferred;
|
|
•
|
Intangible assets, including valuation methodology, estimations of future revenue and costs, profit allocation rates attributable to the acquired technology, and discount rates;
|
|
•
|
Inventory, including estimated future selling prices, timing of product sales, and completion costs for work in process; and
|
|
•
|
Property, plant, and equipment, including determination of values in a continued-use model.
|
|
|
Page
|
|
|
|
|
Consolidated Financial Statements as of August 29, 2019 and August 30, 2018 and for the fiscal years ended
August 29, 2019, August 30, 2018, and August 31, 2017
|
|
|
|
|
|
Consolidated Statements of Operations
|
|
|
|
|
|
Consolidated Statements of Comprehensive Income
|
|
|
|
|
|
Consolidated Balance Sheets
|
|
|
|
|
|
Consolidated Statements of Changes in Equity
|
|
|
|
|
|
Consolidated Statements of Cash Flows
|
|
|
|
|
|
Notes to Consolidated Financial Statements
|
|
|
|
|
|
Report of Independent Registered Public Accounting Firm
|
|
|
For the year ended
|
|
August 29,
2019 |
|
August 30,
2018 |
|
August 31,
2017 |
||||||
|
Revenue
|
|
$
|
23,406
|
|
|
$
|
30,391
|
|
|
$
|
20,322
|
|
|
Cost of goods sold
|
|
12,704
|
|
|
12,500
|
|
|
11,886
|
|
|||
|
Gross margin
|
|
10,702
|
|
|
17,891
|
|
|
8,436
|
|
|||
|
|
|
|
|
|
|
|
||||||
|
Selling, general, and administrative
|
|
836
|
|
|
813
|
|
|
743
|
|
|||
|
Research and development
|
|
2,441
|
|
|
2,141
|
|
|
1,824
|
|
|||
|
Other operating (income) expense, net
|
|
49
|
|
|
(57
|
)
|
|
1
|
|
|||
|
Operating income
|
|
7,376
|
|
|
14,994
|
|
|
5,868
|
|
|||
|
|
|
|
|
|
|
|
||||||
|
Interest income
|
|
205
|
|
|
120
|
|
|
41
|
|
|||
|
Interest expense
|
|
(128
|
)
|
|
(342
|
)
|
|
(601
|
)
|
|||
|
Other non-operating income (expense), net
|
|
(405
|
)
|
|
(465
|
)
|
|
(112
|
)
|
|||
|
|
|
7,048
|
|
|
14,307
|
|
|
5,196
|
|
|||
|
|
|
|
|
|
|
|
||||||
|
Income tax (provision) benefit
|
|
(693
|
)
|
|
(168
|
)
|
|
(114
|
)
|
|||
|
Equity in net income (loss) of equity method investees
|
|
3
|
|
|
(1
|
)
|
|
8
|
|
|||
|
Net income
|
|
6,358
|
|
|
14,138
|
|
|
5,090
|
|
|||
|
|
|
|
|
|
|
|
||||||
|
Net income attributable to noncontrolling interests
|
|
(45
|
)
|
|
(3
|
)
|
|
(1
|
)
|
|||
|
Net income attributable to Micron
|
|
$
|
6,313
|
|
|
$
|
14,135
|
|
|
$
|
5,089
|
|
|
|
|
|
|
|
|
|
||||||
|
Earnings per share
|
|
|
|
|
|
|
||||||
|
Basic
|
|
$
|
5.67
|
|
|
$
|
12.27
|
|
|
$
|
4.67
|
|
|
Diluted
|
|
5.51
|
|
|
11.51
|
|
|
4.41
|
|
|||
|
|
|
|
|
|
|
|
||||||
|
Number of shares used in per share calculations
|
|
|
|
|
|
|
||||||
|
Basic
|
|
1,114
|
|
|
1,152
|
|
|
1,089
|
|
|||
|
Diluted
|
|
1,143
|
|
|
1,229
|
|
|
1,154
|
|
|||
|
For the year ended
|
|
August 29,
2019 |
|
August 30,
2018 |
|
August 31,
2017 |
||||||
|
Net income
|
|
$
|
6,358
|
|
|
$
|
14,138
|
|
|
$
|
5,090
|
|
|
|
|
|
|
|
|
|
||||||
|
Other comprehensive income (loss), net of tax
|
|
|
|
|
|
|
||||||
|
Pension liability adjustments
|
|
(6
|
)
|
|
(3
|
)
|
|
1
|
|
|||
|
Gains (losses) on derivative instruments
|
|
(3
|
)
|
|
(15
|
)
|
|
15
|
|
|||
|
Foreign currency translation adjustments
|
|
(1
|
)
|
|
1
|
|
|
48
|
|
|||
|
Gains (losses) on investments
|
|
9
|
|
|
(2
|
)
|
|
—
|
|
|||
|
Other comprehensive income (loss)
|
|
(1
|
)
|
|
(19
|
)
|
|
64
|
|
|||
|
Total comprehensive income
|
|
6,357
|
|
|
14,119
|
|
|
5,154
|
|
|||
|
Comprehensive income attributable to noncontrolling interests
|
|
(45
|
)
|
|
(3
|
)
|
|
(1
|
)
|
|||
|
Comprehensive income attributable to Micron
|
|
$
|
6,312
|
|
|
$
|
14,116
|
|
|
$
|
5,153
|
|
|
As of
|
|
August 29,
2019 |
|
August 30,
2018 |
||||
|
Assets
|
|
|
|
|
||||
|
Cash and equivalents
|
|
$
|
7,152
|
|
|
$
|
6,506
|
|
|
Short-term investments
|
|
803
|
|
|
296
|
|
||
|
Receivables
|
|
3,195
|
|
|
5,478
|
|
||
|
Inventories
|
|
5,118
|
|
|
3,595
|
|
||
|
Other current assets
|
|
235
|
|
|
164
|
|
||
|
Total current assets
|
|
16,503
|
|
|
16,039
|
|
||
|
Long-term marketable investments
|
|
1,164
|
|
|
473
|
|
||
|
Property, plant, and equipment
|
|
28,240
|
|
|
23,672
|
|
||
|
Intangible assets
|
|
340
|
|
|
331
|
|
||
|
Deferred tax assets
|
|
837
|
|
|
1,022
|
|
||
|
Goodwill
|
|
1,228
|
|
|
1,228
|
|
||
|
Other noncurrent assets
|
|
575
|
|
|
611
|
|
||
|
Total assets
|
|
$
|
48,887
|
|
|
$
|
43,376
|
|
|
|
|
|
|
|
||||
|
Liabilities and equity
|
|
|
|
|
||||
|
Accounts payable and accrued expenses
|
|
$
|
4,626
|
|
|
$
|
4,374
|
|
|
Current debt
|
|
1,310
|
|
|
859
|
|
||
|
Other current liabilities
|
|
454
|
|
|
521
|
|
||
|
Total current liabilities
|
|
6,390
|
|
|
5,754
|
|
||
|
Long-term debt
|
|
4,541
|
|
|
3,777
|
|
||
|
Noncurrent unearned government incentives
|
|
636
|
|
|
227
|
|
||
|
Other noncurrent liabilities
|
|
452
|
|
|
354
|
|
||
|
Total liabilities
|
|
12,019
|
|
|
10,112
|
|
||
|
|
|
|
|
|
||||
|
Commitments and contingencies
|
|
|
|
|
|
|
||
|
|
|
|
|
|
||||
|
Redeemable convertible notes
|
|
—
|
|
|
3
|
|
||
|
Redeemable noncontrolling interest
|
|
98
|
|
|
97
|
|
||
|
|
|
|
|
|
||||
|
Micron shareholders' equity
|
|
|
|
|
||||
|
Common stock, $0.10 par value, 3,000 shares authorized, 1,182 shares issued and 1,106 outstanding (1,170 shares issued and 1,161 outstanding as of August 30, 2018)
|
|
118
|
|
|
117
|
|
||
|
Additional capital
|
|
8,214
|
|
|
8,201
|
|
||
|
Retained earnings
|
|
30,761
|
|
|
24,395
|
|
||
|
Treasury stock, 76 shares held (9 shares as of August 30, 2018)
|
|
(3,221
|
)
|
|
(429
|
)
|
||
|
Accumulated other comprehensive income
|
|
9
|
|
|
10
|
|
||
|
Total Micron shareholders' equity
|
|
35,881
|
|
|
32,294
|
|
||
|
Noncontrolling interests in subsidiaries
|
|
889
|
|
|
870
|
|
||
|
Total equity
|
|
36,770
|
|
|
33,164
|
|
||
|
Total liabilities and equity
|
|
$
|
48,887
|
|
|
$
|
43,376
|
|
|
|
|
Micron Shareholders
|
|
|
|
|
|||||||||||||||||||||||||||||
|
|
|
Common Stock
|
|
Additional Capital
|
|
Retained Earnings
|
|
Treasury Stock
|
|
Accumulated Other Comprehensive
Income (Loss)
|
|
Total Micron Shareholders' Equity
|
|
Noncontrolling Interests in Subsidiaries
|
|
Total Equity
|
|||||||||||||||||||
|
|
|
Number
of Shares
|
|
Amount
|
|
|
|
|
|
|
|
||||||||||||||||||||||||
|
Balance at September 1, 2016
|
|
1,094
|
|
|
$
|
109
|
|
|
$
|
7,736
|
|
|
$
|
5,299
|
|
|
$
|
(1,029
|
)
|
|
$
|
(35
|
)
|
|
$
|
12,080
|
|
|
$
|
848
|
|
|
$
|
12,928
|
|
|
Net income
|
|
|
|
|
|
|
|
5,089
|
|
|
|
|
|
|
5,089
|
|
|
1
|
|
|
5,090
|
|
|||||||||||||
|
Other comprehensive income (loss), net
|
|
|
|
|
|
|
|
|
|
|
|
64
|
|
|
64
|
|
|
|
|
64
|
|
||||||||||||||
|
Stock issued under stock plans
|
|
20
|
|
|
3
|
|
|
139
|
|
|
|
|
|
|
|
|
142
|
|
|
|
|
142
|
|
||||||||||||
|
Stock-based compensation expense
|
|
|
|
|
|
217
|
|
|
(2
|
)
|
|
|
|
|
|
215
|
|
|
|
|
215
|
|
|||||||||||||
|
Repurchase and retirement of stock
|
|
(2
|
)
|
|
—
|
|
|
(13
|
)
|
|
(22
|
)
|
|
|
|
|
|
|
(35
|
)
|
|
|
|
(35
|
)
|
||||||||||
|
Stock issued to Nanya for Inotera Acquisition
|
|
4
|
|
|
—
|
|
|
70
|
|
|
(104
|
)
|
|
1,029
|
|
|
|
|
995
|
|
|
|
|
995
|
|
||||||||||
|
Settlement of capped calls
|
|
|
|
|
|
192
|
|
|
|
|
(67
|
)
|
|
|
|
125
|
|
|
|
|
125
|
|
|||||||||||||
|
Reclassification of redeemable convertible notes, net
|
|
|
|
|
|
(21
|
)
|
|
|
|
|
|
|
|
(21
|
)
|
|
|
|
(21
|
)
|
||||||||||||||
|
Conversion of convertible notes
|
|
|
|
|
|
(33
|
)
|
|
|
|
|
|
|
|
(33
|
)
|
|
|
|
(33
|
)
|
||||||||||||||
|
Balance at August 31, 2017
|
|
1,116
|
|
|
$
|
112
|
|
|
$
|
8,287
|
|
|
$
|
10,260
|
|
|
$
|
(67
|
)
|
|
$
|
29
|
|
|
$
|
18,621
|
|
|
$
|
849
|
|
|
$
|
19,470
|
|
|
Net income
|
|
|
|
|
|
|
|
14,135
|
|
|
|
|
|
|
14,135
|
|
|
3
|
|
|
14,138
|
|
|||||||||||||
|
Other comprehensive income (loss), net
|
|
|
|
|
|
|
|
|
|
|
|
(19
|
)
|
|
(19
|
)
|
|
|
|
|
(19
|
)
|
|||||||||||||
|
Stock issued in public offering
|
|
34
|
|
|
3
|
|
|
1,363
|
|
|
|
|
|
|
|
|
1,366
|
|
|
|
|
1,366
|
|
||||||||||||
|
Stock issued under stock plans
|
|
22
|
|
|
2
|
|
|
287
|
|
|
|
|
|
|
|
|
289
|
|
|
|
|
289
|
|
||||||||||||
|
Stock-based compensation expense
|
|
|
|
|
|
198
|
|
|
|
|
|
|
|
|
198
|
|
|
|
|
198
|
|
||||||||||||||
|
Contributions from noncontrolling interest
|
|
|
|
|
|
|
|
|
|
|
|
|
|
—
|
|
|
18
|
|
|
18
|
|
||||||||||||||
|
Repurchase and retirement of stock
|
|
(2
|
)
|
|
—
|
|
|
(71
|
)
|
|
|
|
|
|
|
|
(71
|
)
|
|
|
|
(71
|
)
|
||||||||||||
|
Settlement of capped calls
|
|
|
|
|
|
429
|
|
|
|
|
(429
|
)
|
|
|
|
—
|
|
|
|
|
—
|
|
|||||||||||||
|
Reclassification of redeemable convertible notes, net
|
|
|
|
|
|
18
|
|
|
|
|
|
|
|
|
18
|
|
|
|
|
18
|
|
||||||||||||||
|
Conversion and repurchase of convertible notes
|
|
|
|
|
|
(2,310
|
)
|
|
|
|
67
|
|
|
|
|
(2,243
|
)
|
|
|
|
(2,243
|
)
|
|||||||||||||
|
Balance at August 30, 2018
|
|
1,170
|
|
|
$
|
117
|
|
|
$
|
8,201
|
|
|
$
|
24,395
|
|
|
$
|
(429
|
)
|
|
$
|
10
|
|
|
$
|
32,294
|
|
|
$
|
870
|
|
|
$
|
33,164
|
|
|
Cumulative effect of adopting new
accounting standards
|
|
|
|
|
|
|
|
92
|
|
|
|
|
|
|
92
|
|
|
|
|
92
|
|
||||||||||||||
|
Net income
|
|
|
|
|
|
|
|
6,313
|
|
|
|
|
|
|
6,313
|
|
|
36
|
|
|
6,349
|
|
|||||||||||||
|
Other comprehensive income (loss), net
|
|
|
|
|
|
|
|
|
|
|
|
(1
|
)
|
|
(1
|
)
|
|
|
|
(1
|
)
|
||||||||||||||
|
Stock issued under stock plans
|
|
14
|
|
|
1
|
|
|
178
|
|
|
|
|
|
|
|
|
179
|
|
|
|
|
179
|
|
||||||||||||
|
Stock-based compensation expense
|
|
|
|
|
|
243
|
|
|
|
|
|
|
|
|
243
|
|
|
|
|
243
|
|
||||||||||||||
|
Repurchase of stock
|
|
(2
|
)
|
|
—
|
|
|
103
|
|
|
(39
|
)
|
|
(2,792
|
)
|
|
|
|
(2,728
|
)
|
|
|
|
(2,728
|
)
|
||||||||||
|
Acquisitions of noncontrolling interests
|
|
|
|
|
|
1
|
|
|
|
|
|
|
|
|
1
|
|
|
(17
|
)
|
|
(16
|
)
|
|||||||||||||
|
Reclassification of redeemable convertible notes, net
|
|
|
|
|
|
3
|
|
|
|
|
|
|
|
|
3
|
|
|
|
|
3
|
|
||||||||||||||
|
Conversion of convertible notes
|
|
|
|
|
|
(515
|
)
|
|
|
|
|
|
|
|
(515
|
)
|
|
|
|
(515
|
)
|
||||||||||||||
|
Balance at August 29, 2019
|
|
1,182
|
|
|
$
|
118
|
|
|
$
|
8,214
|
|
|
$
|
30,761
|
|
|
$
|
(3,221
|
)
|
|
$
|
9
|
|
|
$
|
35,881
|
|
|
$
|
889
|
|
|
$
|
36,770
|
|
|
For the year ended
|
|
August 29,
2019 |
|
August 30,
2018 |
|
August 31,
2017 |
||||||
|
Cash flows from operating activities
|
|
|
|
|
|
|
||||||
|
Net income
|
|
$
|
6,358
|
|
|
$
|
14,138
|
|
|
$
|
5,090
|
|
|
Adjustments to reconcile net income to net cash provided by operating activities
|
|
|
|
|
|
|
|
|
||||
|
Depreciation expense and amortization of intangible assets
|
|
5,424
|
|
|
4,759
|
|
|
3,861
|
|
|||
|
Amortization of debt discount and other costs
|
|
49
|
|
|
101
|
|
|
125
|
|
|||
|
Loss on debt prepayments, repurchases, and conversions
|
|
396
|
|
|
385
|
|
|
99
|
|
|||
|
Stock-based compensation
|
|
243
|
|
|
198
|
|
|
215
|
|
|||
|
Gain on remeasurement of previously-held equity interest in Inotera
|
|
—
|
|
|
—
|
|
|
(71
|
)
|
|||
|
Change in operating assets and liabilities
|
|
|
|
|
|
|
|
|
||||
|
Receivables
|
|
2,431
|
|
|
(1,734
|
)
|
|
(1,651
|
)
|
|||
|
Inventories
|
|
(1,528
|
)
|
|
(472
|
)
|
|
50
|
|
|||
|
Accounts payable and accrued expenses
|
|
(174
|
)
|
|
668
|
|
|
456
|
|
|||
|
Payments attributed to intercompany balances with Inotera
|
|
—
|
|
|
—
|
|
|
(361
|
)
|
|||
|
Deferred income taxes, net
|
|
150
|
|
|
(265
|
)
|
|
(22
|
)
|
|||
|
Other
|
|
(160
|
)
|
|
(378
|
)
|
|
362
|
|
|||
|
Net cash provided by operating activities
|
|
13,189
|
|
|
17,400
|
|
|
8,153
|
|
|||
|
|
|
|
|
|
|
|
||||||
|
Cash flows from investing activities
|
|
|
|
|
|
|
|
|
||||
|
Expenditures for property, plant, and equipment
|
|
(9,780
|
)
|
|
(8,879
|
)
|
|
(4,734
|
)
|
|||
|
Purchases of available-for-sale securities
|
|
(4,218
|
)
|
|
(760
|
)
|
|
(1,239
|
)
|
|||
|
Acquisition of Inotera
|
|
—
|
|
|
—
|
|
|
(2,634
|
)
|
|||
|
Proceeds from maturities of available-for-sale securities
|
|
1,541
|
|
|
320
|
|
|
194
|
|
|||
|
Proceeds from sales of available-for-sale securities
|
|
1,504
|
|
|
604
|
|
|
776
|
|
|||
|
Proceeds from government incentives
|
|
748
|
|
|
355
|
|
|
21
|
|
|||
|
Other
|
|
120
|
|
|
144
|
|
|
79
|
|
|||
|
Net cash provided by (used for) investing activities
|
|
(10,085
|
)
|
|
(8,216
|
)
|
|
(7,537
|
)
|
|||
|
|
|
|
|
|
|
|
||||||
|
Cash flows from financing activities
|
|
|
|
|
|
|
|
|
||||
|
Repayments of debt
|
|
(3,340
|
)
|
|
(10,194
|
)
|
|
(2,558
|
)
|
|||
|
Payments to acquire treasury stock
|
|
(2,729
|
)
|
|
(71
|
)
|
|
(36
|
)
|
|||
|
Payments on equipment purchase contracts
|
|
(75
|
)
|
|
(206
|
)
|
|
(519
|
)
|
|||
|
Proceeds from issuance of debt
|
|
3,550
|
|
|
1,009
|
|
|
3,311
|
|
|||
|
Proceeds from issuance of stock
|
|
179
|
|
|
1,655
|
|
|
142
|
|
|||
|
Other
|
|
(23
|
)
|
|
31
|
|
|
9
|
|
|||
|
Net cash provided by (used for) financing activities
|
|
(2,438
|
)
|
|
(7,776
|
)
|
|
349
|
|
|||
|
|
|
|
|
|
|
|
||||||
|
Effect of changes in currency exchange rates on cash, cash equivalents, and restricted cash
|
|
26
|
|
|
(37
|
)
|
|
(12
|
)
|
|||
|
|
|
|
|
|
|
|
||||||
|
Net increase in cash, cash equivalents, and restricted cash
|
|
692
|
|
|
1,371
|
|
|
953
|
|
|||
|
Cash, cash equivalents, and restricted cash at beginning of period
|
|
6,587
|
|
|
5,216
|
|
|
4,263
|
|
|||
|
Cash, cash equivalents, and restricted cash at end of period
|
|
$
|
7,279
|
|
|
$
|
6,587
|
|
|
$
|
5,216
|
|
|
|
|
|
|
|
|
|
||||||
|
Supplemental disclosures
|
|
|
|
|
|
|
|
|
||||
|
Income taxes paid, net
|
|
$
|
(524
|
)
|
|
$
|
(226
|
)
|
|
$
|
(99
|
)
|
|
Interest paid, net of amounts capitalized
|
|
(53
|
)
|
|
(312
|
)
|
|
(468
|
)
|
|||
|
Noncash investing and financing activity
|
|
|
|
|
|
|
||||||
|
Equipment acquisitions on contracts payable and capital leases
|
|
119
|
|
|
84
|
|
|
813
|
|
|||
|
|
|
|
|
|
|
|
|
||||||||
|
|
Ending Balance
as of
August 30, 2018
|
|
ASU 2016-16
|
|
ASC 606
|
|
Opening Balance
as of
August 31, 2018
|
||||||||
|
Receivables
|
$
|
5,478
|
|
|
$
|
—
|
|
|
$
|
114
|
|
|
$
|
5,592
|
|
|
Inventories
|
3,595
|
|
|
—
|
|
|
(5
|
)
|
|
3,590
|
|
||||
|
Other current assets
|
164
|
|
|
(14
|
)
|
|
30
|
|
|
180
|
|
||||
|
Deferred tax assets
|
1,022
|
|
|
56
|
|
|
(92
|
)
|
|
986
|
|
||||
|
Other current liabilities
|
521
|
|
|
—
|
|
|
(4
|
)
|
|
517
|
|
||||
|
Other noncurrent liabilities
|
354
|
|
|
—
|
|
|
1
|
|
|
355
|
|
||||
|
Retained earnings
|
24,395
|
|
|
42
|
|
|
50
|
|
|
24,487
|
|
||||
|
|
|
Year ended August 29, 2019
|
||||||||||
|
|
|
As Reported
|
|
Adjustments
|
|
Amounts Without the Effects of Adoption of ASC 606
|
||||||
|
Revenue
|
|
$
|
23,406
|
|
|
$
|
(40
|
)
|
|
$
|
23,366
|
|
|
Cost of goods sold
|
|
12,704
|
|
|
(70
|
)
|
|
12,634
|
|
|||
|
Interest expense
|
|
(128
|
)
|
|
5
|
|
|
(123
|
)
|
|||
|
Income tax (provision) benefit
|
|
(693
|
)
|
|
(19
|
)
|
|
(712
|
)
|
|||
|
Net income attributable to Micron
|
|
6,313
|
|
|
16
|
|
|
6,329
|
|
|||
|
As of August 29, 2019
|
|
As Reported
|
|
Adjustments
|
|
Amounts Without the Effects of Adoption of ASC 606
|
||||||
|
Receivables
|
|
$
|
3,195
|
|
|
$
|
(94
|
)
|
|
$
|
3,101
|
|
|
Other current assets
|
|
235
|
|
|
(44
|
)
|
|
191
|
|
|||
|
Deferred tax assets
|
|
837
|
|
|
79
|
|
|
916
|
|
|||
|
Accounts payable and accrued expenses
|
|
4,626
|
|
|
6
|
|
|
4,632
|
|
|||
|
Other current liabilities
|
|
454
|
|
|
(30
|
)
|
|
424
|
|
|||
|
Other noncurrent liabilities
|
|
452
|
|
|
(1
|
)
|
|
451
|
|
|||
|
Retained earnings
|
|
30,761
|
|
|
(34
|
)
|
|
30,727
|
|
|||
|
Consideration
|
|
|
||
|
Cash paid for Inotera Acquisition
|
|
$
|
4,099
|
|
|
Less cash received from sale of Micron Shares
|
|
(986
|
)
|
|
|
Net cash paid for Inotera Acquisition
|
|
3,113
|
|
|
|
Fair value of our previously-held equity interest in Inotera
|
|
1,441
|
|
|
|
Fair value of Micron Shares exchanged for Inotera shares
|
|
995
|
|
|
|
Other
|
|
3
|
|
|
|
Payments attributed to intercompany balances with Inotera
|
|
(361
|
)
|
|
|
|
|
$
|
5,191
|
|
|
|
|
|
||
|
Assets acquired and liabilities assumed
|
|
|
||
|
Cash and equivalents
|
|
$
|
118
|
|
|
Inventories
|
|
285
|
|
|
|
Other current assets
|
|
27
|
|
|
|
Property, plant, and equipment
|
|
3,722
|
|
|
|
Deferred tax assets
|
|
82
|
|
|
|
Goodwill
|
|
1,124
|
|
|
|
Other noncurrent assets
|
|
130
|
|
|
|
Accounts payable and accrued expenses
|
|
(232
|
)
|
|
|
Debt
|
|
(56
|
)
|
|
|
Other noncurrent liabilities
|
|
(9
|
)
|
|
|
|
|
$
|
5,191
|
|
|
Year ended
|
|
August 31,
2017 |
||
|
Net sales
|
|
$
|
20,317
|
|
|
Net income
|
|
5,172
|
|
|
|
Net income attributable to Micron
|
|
5,171
|
|
|
|
Earnings per share
|
|
|
||
|
Basic
|
|
4.68
|
|
|
|
Diluted
|
|
4.42
|
|
|
|
As of
|
|
2019
|
|
2018
|
||||||||||||||||||||||||||||
|
|
|
Cash and Equivalents
|
|
Short-term Investments
|
|
Long-term Marketable Investments
(1)
|
|
Total Fair Value
|
|
Cash and Equivalents
|
|
Short-term Investments
|
|
Long-term Marketable Investments
(1)
|
|
Total Fair Value
|
||||||||||||||||
|
Cash
|
|
$
|
2,388
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
2,388
|
|
|
$
|
3,223
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
3,223
|
|
|
Level 1
(2)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||
|
Money market funds
|
|
3,418
|
|
|
—
|
|
|
—
|
|
|
3,418
|
|
|
2,443
|
|
|
—
|
|
|
—
|
|
|
2,443
|
|
||||||||
|
Level 2
(3)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||
|
Certificates of deposits
|
|
1,292
|
|
|
13
|
|
|
1
|
|
|
1,306
|
|
|
806
|
|
|
11
|
|
|
2
|
|
|
819
|
|
||||||||
|
Corporate bonds
|
|
—
|
|
|
550
|
|
|
689
|
|
|
1,239
|
|
|
3
|
|
|
172
|
|
|
272
|
|
|
447
|
|
||||||||
|
Government securities
|
|
36
|
|
|
149
|
|
|
232
|
|
|
417
|
|
|
5
|
|
|
63
|
|
|
103
|
|
|
171
|
|
||||||||
|
Asset-backed securities
|
|
—
|
|
|
67
|
|
|
242
|
|
|
309
|
|
|
—
|
|
|
34
|
|
|
96
|
|
|
130
|
|
||||||||
|
Commercial paper
|
|
18
|
|
|
24
|
|
|
—
|
|
|
42
|
|
|
26
|
|
|
16
|
|
|
—
|
|
|
42
|
|
||||||||
|
|
|
7,152
|
|
|
$
|
803
|
|
|
$
|
1,164
|
|
|
$
|
9,119
|
|
|
6,506
|
|
|
$
|
296
|
|
|
$
|
473
|
|
|
$
|
7,275
|
|
||
|
Restricted cash
(4)
|
|
127
|
|
|
|
|
|
|
|
|
81
|
|
|
|
|
|
|
|
||||||||||||||
|
Cash, cash equivalents, and restricted cash
|
|
$
|
7,279
|
|
|
|
|
|
|
|
|
$
|
6,587
|
|
|
|
|
|
|
|
||||||||||||
|
(1)
|
The maturities of long-term marketable securities range from
one
to
four
years.
|
|
(2)
|
The fair value of Level 1 securities is measured based on quoted prices in active markets for identical assets.
|
|
(3)
|
The fair value of Level 2 securities is measured using information obtained from pricing services, which obtain quoted market prices for similar instruments, non-binding market consensus prices that are corroborated by observable market data, or various other methodologies, to determine the appropriate value at the measurement date. We perform supplemental analysis to validate information obtained from these pricing services. No adjustments were made to the fair values indicated by such pricing information as of
August 29, 2019
or
August 30, 2018
.
|
|
(4)
|
Restricted cash is included in other noncurrent assets and primarily relates to the MMJ Creditor Payments and government incentives received prior to being earned. The restrictions lapse on the MMJ Creditor Payments upon approval by the trustees and/or Tokyo District Court and for the government incentives upon achieving certain performance conditions.
|
|
As of
|
|
2019
|
|
2018
|
||||
|
Trade receivables
|
|
$
|
2,778
|
|
|
$
|
5,056
|
|
|
Income and other taxes
|
|
242
|
|
|
161
|
|
||
|
Other
|
|
175
|
|
|
261
|
|
||
|
|
|
$
|
3,195
|
|
|
$
|
5,478
|
|
|
As of
|
|
2019
|
|
2018
|
||||
|
Finished goods
|
|
$
|
757
|
|
|
$
|
815
|
|
|
Work in process
|
|
3,825
|
|
|
2,357
|
|
||
|
Raw materials and supplies
|
|
536
|
|
|
423
|
|
||
|
|
|
$
|
5,118
|
|
|
$
|
3,595
|
|
|
As of
|
|
2019
|
|
2018
|
||||
|
Land
|
|
$
|
352
|
|
|
$
|
345
|
|
|
Buildings (includes $528 and $483, respectively, under capital leases)
|
|
10,931
|
|
|
8,680
|
|
||
|
Equipment
(1)
(includes $905 and $1,336, respectively, under capital leases)
|
|
44,051
|
|
|
38,249
|
|
||
|
Construction in progress
(2)
|
|
1,700
|
|
|
1,162
|
|
||
|
Software
|
|
790
|
|
|
655
|
|
||
|
|
|
57,824
|
|
|
49,091
|
|
||
|
Accumulated depreciation (includes $733 and $868, respectively, under capital leases)
|
|
(29,584
|
)
|
|
(25,419
|
)
|
||
|
|
|
$
|
28,240
|
|
|
$
|
23,672
|
|
|
(1)
|
Included costs related to equipment not placed into service of
$2.33 billion
as of
August 29, 2019
and
$1.73 billion
as of
August 30, 2018
.
|
|
(2)
|
Included building-related construction, tool installation, and software costs for assets not placed into service.
|
|
As of
|
|
2019
|
|
2018
|
||||||||||||
|
|
|
Gross
Amount
|
|
Accumulated
Amortization
|
|
Gross
Amount
|
|
Accumulated
Amortization
|
||||||||
|
Amortizing assets
|
|
|
|
|
|
|
|
|
||||||||
|
Product and process technology
|
|
$
|
583
|
|
|
$
|
(243
|
)
|
|
$
|
567
|
|
|
$
|
(344
|
)
|
|
Non-amortizing assets
|
|
|
|
|
|
|
|
|
||||||||
|
In-process R&D
|
|
—
|
|
|
—
|
|
|
108
|
|
|
—
|
|
||||
|
Total intangible assets
|
|
$
|
583
|
|
|
$
|
(243
|
)
|
|
$
|
675
|
|
|
$
|
(344
|
)
|
|
|
|
|
|
|
|
|
|
|
||||||||
|
Goodwill
|
|
$
|
1,228
|
|
|
|
|
$
|
1,228
|
|
|
|
||||
|
As of
|
|
2019
|
|
2018
|
||||
|
Accounts payable
|
|
$
|
1,677
|
|
|
$
|
1,692
|
|
|
Property, plant, and equipment
|
|
1,782
|
|
|
1,238
|
|
||
|
Salaries, wages, and benefits
|
|
695
|
|
|
841
|
|
||
|
Income and other taxes
|
|
309
|
|
|
402
|
|
||
|
Other
|
|
163
|
|
|
201
|
|
||
|
|
|
$
|
4,626
|
|
|
$
|
4,374
|
|
|
As of
|
|
2019
|
|
2018
|
||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
Net Carrying Amount
|
|
|
|
Net Carrying Amount
|
||||||||||||||||||||||||||
|
Instrument
|
|
Stated Rate
|
|
Effective Rate
|
|
Principal
|
|
Current
|
|
Long-Term
|
|
Total
(1)
|
|
Principal
|
|
Current
|
|
Long-Term
|
|
Total
(1)
|
||||||||||||||||||
|
IMFT Member Debt
|
|
N/A
|
|
|
N/A
|
|
|
$
|
693
|
|
|
$
|
693
|
|
|
$
|
—
|
|
|
$
|
693
|
|
|
$
|
1,009
|
|
|
$
|
—
|
|
|
$
|
1,009
|
|
|
$
|
1,009
|
|
|
Capital lease obligations
|
|
N/A
|
|
|
4.30
|
%
|
|
591
|
|
|
223
|
|
|
368
|
|
|
591
|
|
|
846
|
|
|
310
|
|
|
536
|
|
|
846
|
|
||||||||
|
MMJ Creditor Payments
|
|
N/A
|
|
|
9.76
|
%
|
|
206
|
|
|
198
|
|
|
—
|
|
|
198
|
|
|
520
|
|
|
$
|
309
|
|
|
183
|
|
|
492
|
|
|||||||
|
2024 Notes
|
|
4.64
|
%
|
|
4.76
|
%
|
|
600
|
|
|
—
|
|
|
597
|
|
|
597
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
||||||||
|
2025 Notes
|
|
5.50
|
%
|
|
5.56
|
%
|
|
519
|
|
|
—
|
|
|
516
|
|
|
516
|
|
|
519
|
|
|
—
|
|
|
515
|
|
|
515
|
|
||||||||
|
2026 Notes
|
|
4.98
|
%
|
|
5.07
|
%
|
|
500
|
|
|
—
|
|
|
497
|
|
|
497
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
||||||||
|
2027 Notes
|
|
4.19
|
%
|
|
4.27
|
%
|
|
900
|
|
|
—
|
|
|
895
|
|
|
895
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
||||||||
|
2029 Notes
|
|
5.33
|
%
|
|
5.40
|
%
|
|
700
|
|
|
—
|
|
|
696
|
|
|
696
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
||||||||
|
2030 Notes
|
|
4.66
|
%
|
|
4.73
|
%
|
|
850
|
|
|
—
|
|
|
845
|
|
|
845
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
||||||||
|
2032D Notes
(2)
|
|
3.13
|
%
|
|
6.33
|
%
|
|
134
|
|
|
—
|
|
|
127
|
|
|
127
|
|
|
143
|
|
|
—
|
|
|
132
|
|
|
132
|
|
||||||||
|
2033F Notes
(2)(3)
|
|
2.13
|
%
|
|
4.93
|
%
|
|
62
|
|
|
196
|
|
|
—
|
|
|
196
|
|
|
107
|
|
|
235
|
|
|
—
|
|
|
235
|
|
||||||||
|
2043G Notes
|
|
3.00
|
%
|
|
6.76
|
%
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
1,019
|
|
|
—
|
|
|
682
|
|
|
682
|
|
||||||||
|
2022 Term
Loan B
|
|
4.24
|
%
|
|
4.65
|
%
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
735
|
|
|
5
|
|
|
720
|
|
|
725
|
|
||||||||
|
|
|
|
|
|
|
$
|
5,755
|
|
|
$
|
1,310
|
|
|
$
|
4,541
|
|
|
$
|
5,851
|
|
|
$
|
4,898
|
|
|
$
|
859
|
|
|
$
|
3,777
|
|
|
$
|
4,636
|
|
||
|
(1)
|
Net carrying amount is the principal amount less unamortized debt discount and issuance costs. In addition, the net carrying amount as of
August 29, 2019
and
August 30, 2018
included
$135 million
and
$132 million
, respectively, of derivative debt liabilities recognized as a result of our election to settle entirely in cash converted notes with an aggregate principal amount of
$44 million
and
$35 million
, respectively.
|
|
(2)
|
Since the closing price of our common stock exceeded
130%
of the conversion price per share for at least
20
trading days in the
30
trading day period ended on June 30, 2019, these notes are convertible by the holders through the calendar quarter ended September 30, 2019. Additionally, the closing price of our common stock also exceeded the thresholds for the calendar quarter ended September 30, 2019; therefore, these notes are convertible by the holders at any time through December 31, 2019.
|
|
(3)
|
Current debt as of
August 29, 2019
included an aggregate of
$179 million
for the settlement obligation (including principal and amounts in excess of principal) for conversions of our 2033F Notes that settled in cash in the first quarter of 2020. The remainder of the 2033F Notes were classified as current as of
August 29, 2019
because the terms of these notes require us to pay cash for the principal amount of any converted notes and holders of these notes had the right to convert their notes as of that date.
|
|
2020
|
|
¥
|
21,757
|
|
|
$
|
206
|
|
|
Less unamortized discount
|
|
(709
|
)
|
|
(8
|
)
|
||
|
|
|
¥
|
21,048
|
|
|
$
|
198
|
|
|
|
|
Holder Put
Date (1) |
|
Maturity Date
|
|
Conversion Price Per Share
|
|
Conversion Price Per Share Threshold
(2)
|
|
Underlying Shares of Common Stock
|
|
Conversion Value in Excess of Principal
(3)
|
|
Principal
Settlement
Option
(4)
|
|||||||
|
2032D Notes
|
|
May 2021
|
|
May 2032
|
|
$
|
9.98
|
|
|
$
|
12.97
|
|
|
13
|
|
|
$
|
464
|
|
|
Cash and/or shares
|
|
2033F Notes
(5)
|
|
Feb. 2020
|
|
Feb. 2033
|
|
10.93
|
|
|
14.21
|
|
|
6
|
|
|
190
|
|
|
Cash
|
|||
|
|
|
|
|
|
|
|
|
|
|
19
|
|
|
$
|
654
|
|
|
|
||||
|
(1)
|
Debt discount and debt issuance costs are amortized through the earliest holder put date.
|
|
(2)
|
Represents
130%
of the conversion price per share. If the trading price of our common stock exceeds such threshold for a specified period, holders may convert such notes during a specified period. See "Conversion Rights" below.
|
|
(3)
|
Based on the trading price of our common stock of
$44.67
as of
August 29, 2019
.
|
|
(4)
|
It is our current intent to settle in cash the principal amount of our convertible notes upon conversion. As a result, only the amounts payable in excess of the principal amounts upon conversion of our convertible notes are considered in diluted earnings per share under the treasury stock method. For each of our convertible notes, we may elect to settle any amounts in excess of the principal in cash, shares of our common stock, or a combination thereof.
|
|
(5)
|
Holders may put their notes to us on February 15, 2020 and on February 15, 2023.
|
|
|
|
Conditional Redemption Period
at Our Option
(1)
|
|
Unconditional Redemption Period
at Our Option
|
|
Redemption Period Requiring
Make-Whole
|
|
2032D Notes
|
|
On or after May 1, 2017
|
|
On or after May 4, 2021
|
|
Prior to May 4, 2021
(2)
|
|
2033F Notes
|
|
N/A
|
|
On or after Feb. 20, 2020
|
|
N/A
|
|
(1)
|
We may redeem for cash on or after the applicable dates if the volume weighted average price of our common stock has been at least
130%
of the conversion price for at least
20
trading days during any
30
consecutive trading day period.
|
|
(2)
|
If we redeem prior to the applicable date, we will pay a make-whole premium in cash equal to the present value of the remaining scheduled interest payments from the redemption date to May 4, 2021.
|
|
|
|
Increase (Decrease) in Principal
|
|
Increase (Decrease) in Carrying Value
|
|
Increase (Decrease) in Cash
|
|
Decrease in Equity
|
|
Gain (Loss)
|
||||||||||
|
Issuances
|
|
|
|
|
|
|
|
|
|
|
||||||||||
|
2024 Notes
(1)
|
|
$
|
600
|
|
|
$
|
597
|
|
|
$
|
597
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
2026 Notes
(1)
|
|
500
|
|
|
497
|
|
|
497
|
|
|
—
|
|
|
—
|
|
|||||
|
2027 Notes
(2)
|
|
900
|
|
|
895
|
|
|
895
|
|
|
—
|
|
|
—
|
|
|||||
|
2029 Notes
(1)
|
|
700
|
|
|
695
|
|
|
695
|
|
|
—
|
|
|
—
|
|
|||||
|
2030 Notes
(2)
|
|
850
|
|
|
845
|
|
|
845
|
|
|
—
|
|
|
—
|
|
|||||
|
Prepayments
|
|
|
|
|
|
|
|
|
|
|
||||||||||
|
2022 Term Loan B
|
|
(728
|
)
|
|
(721
|
)
|
|
(728
|
)
|
|
—
|
|
|
(7
|
)
|
|||||
|
Settled conversions
|
|
|
|
|
|
|
|
|
|
|
||||||||||
|
2032D Notes
|
|
(10
|
)
|
|
(9
|
)
|
|
(35
|
)
|
|
(28
|
)
|
|
2
|
|
|||||
|
2033F Notes
|
|
(45
|
)
|
|
(175
|
)
|
|
(192
|
)
|
|
(28
|
)
|
|
11
|
|
|||||
|
2043G Notes
|
|
(1,019
|
)
|
|
(691
|
)
|
|
(1,426
|
)
|
|
(326
|
)
|
|
(400
|
)
|
|||||
|
Conversions not settled
|
|
|
|
|
|
|
|
|
|
|
||||||||||
|
2033F Notes
(3)
|
|
—
|
|
|
135
|
|
|
—
|
|
|
(133
|
)
|
|
(2
|
)
|
|||||
|
|
|
$
|
1,748
|
|
|
$
|
2,068
|
|
|
$
|
1,148
|
|
|
$
|
(515
|
)
|
|
$
|
(396
|
)
|
|
(1)
|
Issued February 6, 2019.
|
|
(2)
|
Issued July 12, 2019.
|
|
(3)
|
As of
August 29, 2019
, an aggregate of
$44 million
principal amount of our 2033F Notes (with a carrying value of
$179 million
) had converted but not settled. These notes settled in the first quarter of 2020 for
$192 million
in cash.
|
|
|
|
Notes Payable
|
|
Capital Lease Obligations
|
||||
|
2020
|
|
$
|
1,095
|
|
|
$
|
248
|
|
|
2021
|
|
134
|
|
|
107
|
|
||
|
2022
|
|
—
|
|
|
73
|
|
||
|
2023
|
|
—
|
|
|
48
|
|
||
|
2024
|
|
600
|
|
|
37
|
|
||
|
2025 and thereafter
|
|
3,469
|
|
|
189
|
|
||
|
Unamortized discounts and interest, respectively
|
|
(38
|
)
|
|
(111
|
)
|
||
|
|
|
$
|
5,260
|
|
|
$
|
591
|
|
|
2020
|
|
$
|
54
|
|
|
2021
|
|
64
|
|
|
|
2022
|
|
63
|
|
|
|
2023
|
|
59
|
|
|
|
2024
|
|
53
|
|
|
|
2025 and thereafter
|
|
459
|
|
|
|
|
|
$
|
752
|
|
|
|
Pension Liability Adjustments
|
|
Gains (Losses) on Derivative Instruments
|
|
Cumulative Foreign Currency Translation Adjustment
|
|
Unrealized Gains (Losses) on Investments
|
|
Total
|
||||||||||
|
As of August 30, 2018
|
$
|
10
|
|
|
$
|
2
|
|
|
$
|
—
|
|
|
$
|
(2
|
)
|
|
$
|
10
|
|
|
Other comprehensive income
|
(13
|
)
|
|
(3
|
)
|
|
(1
|
)
|
|
14
|
|
|
(3
|
)
|
|||||
|
Amount reclassified out of accumulated other comprehensive income
|
4
|
|
|
—
|
|
|
—
|
|
|
(3
|
)
|
|
1
|
|
|||||
|
Tax effects
|
3
|
|
|
—
|
|
|
—
|
|
|
(2
|
)
|
|
1
|
|
|||||
|
Other comprehensive income
|
(6
|
)
|
|
(3
|
)
|
|
(1
|
)
|
|
9
|
|
|
(1
|
)
|
|||||
|
As of August 29, 2019
|
$
|
4
|
|
|
$
|
(1
|
)
|
|
$
|
(1
|
)
|
|
$
|
7
|
|
|
$
|
9
|
|
|
As of
|
|
2019
|
|
2018
|
||||||||||
|
|
|
Balance
|
|
Percentage
|
|
Balance
|
|
Percentage
|
||||||
|
IMFT
|
|
$
|
889
|
|
|
49
|
%
|
|
$
|
853
|
|
|
49
|
%
|
|
Other
|
|
—
|
|
|
—
|
|
|
17
|
|
|
Various
|
|
||
|
|
|
$
|
889
|
|
|
|
|
$
|
870
|
|
|
|
||
|
As of
|
|
2019
|
|
2018
|
||||
|
Assets
|
|
|
|
|
||||
|
Cash and equivalents
|
|
$
|
130
|
|
|
$
|
91
|
|
|
Receivables
|
|
128
|
|
|
126
|
|
||
|
Inventories
|
|
124
|
|
|
114
|
|
||
|
Other current assets
|
|
9
|
|
|
8
|
|
||
|
Total current assets
|
|
391
|
|
|
339
|
|
||
|
Property, plant, and equipment
|
|
2,235
|
|
|
2,641
|
|
||
|
Other noncurrent assets
|
|
38
|
|
|
45
|
|
||
|
Total assets
|
|
$
|
2,664
|
|
|
$
|
3,025
|
|
|
|
|
|
|
|
||||
|
Liabilities
|
|
|
|
|
|
|
||
|
Accounts payable and accrued expenses
|
|
$
|
118
|
|
|
$
|
138
|
|
|
Current debt
|
|
696
|
|
|
20
|
|
||
|
Other current liabilities
|
|
37
|
|
|
9
|
|
||
|
Total current liabilities
|
|
851
|
|
|
167
|
|
||
|
Long-term debt
|
|
53
|
|
|
1,064
|
|
||
|
Other noncurrent liabilities
|
|
5
|
|
|
74
|
|
||
|
Total liabilities
|
|
$
|
909
|
|
|
$
|
1,305
|
|
|
As of
|
|
2019
|
|
2018
|
||||||||||||
|
|
|
Fair
Value
|
|
Carrying
Value
|
|
Fair
Value
|
|
Carrying
Value
|
||||||||
|
Notes and MMJ Creditor Payments
|
|
$
|
5,194
|
|
|
$
|
4,937
|
|
|
$
|
2,798
|
|
|
$
|
2,741
|
|
|
Convertible notes
|
|
852
|
|
|
323
|
|
|
3,124
|
|
|
1,049
|
|
||||
|
|
|
Gross Notional Amount
|
|
Fair Value of
|
||||||||
|
Current Assets
(1)
|
|
Current Liabilities
(2)
|
||||||||||
|
As of August 29, 2019
|
|
|
|
|
|
|
||||||
|
Derivative instruments with hedge accounting designation
|
|
|
|
|
|
|
||||||
|
Cash flow currency hedges
|
|
$
|
146
|
|
|
$
|
1
|
|
|
$
|
—
|
|
|
|
|
|
|
|
|
|
||||||
|
Derivative instruments without hedge accounting designation
|
|
|
|
|
|
|
||||||
|
Non-designated currency hedges
|
|
1,871
|
|
|
1
|
|
|
(9
|
)
|
|||
|
Convertible notes settlement obligation
(3)
|
|
|
|
—
|
|
|
(179
|
)
|
||||
|
|
|
|
|
1
|
|
|
(188
|
)
|
||||
|
|
|
|
|
|
|
|
||||||
|
|
|
|
|
$
|
2
|
|
|
$
|
(188
|
)
|
||
|
|
|
|
|
|
|
|
||||||
|
As of August 30, 2018
|
|
|
|
|
|
|
||||||
|
Derivative instruments with hedge accounting designation
|
|
|
|
|
|
|
||||||
|
Cash flow currency hedges
|
|
$
|
538
|
|
|
$
|
—
|
|
|
$
|
(13
|
)
|
|
|
|
|
|
|
|
|
||||||
|
Derivative instruments without hedge accounting designation
|
|
|
|
|
|
|
||||||
|
Non-designated currency hedges
|
|
1,919
|
|
|
14
|
|
|
(10
|
)
|
|||
|
Convertible notes settlement obligation
(3)
|
|
|
|
—
|
|
|
(167
|
)
|
||||
|
|
|
|
|
|
14
|
|
|
(177
|
)
|
|||
|
|
|
|
|
|
|
|
||||||
|
|
|
|
|
$
|
14
|
|
|
$
|
(190
|
)
|
||
|
(1)
|
Included in receivables – other.
|
|
(2)
|
Included in accounts payable and accrued expenses – other for forward contracts and in current debt for convertible notes settlement obligations.
|
|
(3)
|
Notional amounts of convertible notes settlement obligations as of
August 29, 2019
and
August 30, 2018
were
4 million
and
3 million
shares of our common stock, respectively.
|
|
|
|
Other
Non-Operating
Income (Expense)
|
||
|
For the year ended
|
|
2018
|
||
|
Loss on remeasurement of hedged assets and liabilities
|
|
$
|
(25
|
)
|
|
Gain on derivatives designated as hedged instruments
|
|
25
|
|
|
|
Amortization of amounts excluded from hedge effectiveness
|
|
(32
|
)
|
|
|
|
|
$
|
(32
|
)
|
|
|
|
Number of Shares
|
|
Weighted-Average Grant Date Fair Value Per Share
|
|||
|
Outstanding as of August 30, 2018
|
|
15
|
|
|
$
|
25.18
|
|
|
Granted
|
|
9
|
|
|
41.11
|
|
|
|
Restrictions lapsed
|
|
(6
|
)
|
|
24.22
|
|
|
|
Canceled
|
|
(2
|
)
|
|
24.79
|
|
|
|
Outstanding as of August 29, 2019
|
|
16
|
|
|
34.72
|
|
|
|
For the year ended
|
|
2019
|
|
2018
|
|
2017
|
|
||||||||||||||
|
Restricted stock award shares granted
|
|
9
|
|
|
4
|
|
|
8
|
|
||||||||||||
|
Weighted-average grant-date fair value per share
|
|
$
|
41.11
|
|
|
$
|
42.48
|
|
|
$
|
18.77
|
|
|||||||||
|
Aggregate vesting-date fair value of shares vested
|
|
$
|
248
|
|
|
$
|
259
|
|
|
$
|
115
|
|
|||||||||
|
|
|
Number of Shares
|
|
Weighted-Average Exercise Price Per Share
|
|
Weighted-Average Remaining Contractual Life
(In Years)
|
|
Aggregate Intrinsic Value
|
|||||
|
Outstanding as of August 30, 2018
|
|
18
|
|
|
$
|
23.38
|
|
|
|
|
|
||
|
Granted
|
|
—
|
|
|
44.30
|
|
|
|
|
|
|||
|
Exercised
|
|
(5
|
)
|
|
17.50
|
|
|
|
|
|
|||
|
Canceled or expired
|
|
(1
|
)
|
|
22.60
|
|
|
|
|
|
|||
|
Outstanding as of August 29, 2019
|
|
12
|
|
|
25.94
|
|
|
4.3
|
|
$
|
220
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||
|
Exercisable as of August 29, 2019
|
|
7
|
|
|
$
|
25.37
|
|
|
3.7
|
|
$
|
143
|
|
|
Unvested as of August 29, 2019
|
|
5
|
|
|
26.94
|
|
|
5.5
|
|
77
|
|
||
|
For the year ended
|
|
2019
|
|
2018
|
|
2017
|
|
||||||||||||||||||
|
Stock options granted
|
|
—
|
|
|
2
|
|
8
|
|
|||||||||||||||||
|
Weighted-average grant-date fair value per share
|
|
$
|
19.50
|
|
$
|
18.65
|
|
$
|
8.68
|
|
|||||||||||||||
|
Average expected life in years
|
|
5.4
|
|
5.5
|
|
5.5
|
|
||||||||||||||||||
|
Weighted-average expected volatility
|
|
44.0
|
%
|
|
|
44.0
|
%
|
|
|
46.0
|
%
|
|
|
||||||||||||
|
Weighted-average risk-free interest rate
|
|
2.9
|
%
|
|
|
2.2
|
%
|
|
|
1.8
|
%
|
|
|
||||||||||||
|
Expected dividend yield
|
|
0.0
|
%
|
|
|
0.0
|
%
|
|
|
0.0
|
%
|
|
|
||||||||||||
|
For the year ended
|
|
2019
|
|
2018
|
|
|||||||||||
|
Weighted-average grant-date fair value per share
|
|
$
|
11.60
|
|
$
|
14.55
|
|
|||||||||
|
Average expected life in years
|
|
0.5
|
|
0.5
|
|
|||||||||||
|
Weighted-average expected volatility
|
|
45.0
|
%
|
|
|
43.0
|
%
|
|
|
|||||||
|
Weighted-average risk-free interest rate
|
|
2.2
|
%
|
|
|
2.2
|
%
|
|
|
|||||||
|
Expected dividend yield
|
|
0.0
|
%
|
|
|
0.0
|
%
|
|
|
|||||||
|
For the year ended
|
|
2019
|
|
2018
|
|
2017
|
||||||
|
Stock-based compensation expense by caption
|
|
|
|
|
|
|
||||||
|
Cost of goods sold
|
|
$
|
102
|
|
|
$
|
83
|
|
|
$
|
88
|
|
|
Selling, general, and administrative
|
|
73
|
|
|
61
|
|
|
75
|
|
|||
|
Research and development
|
|
68
|
|
|
54
|
|
|
52
|
|
|||
|
|
|
$
|
243
|
|
|
$
|
198
|
|
|
$
|
215
|
|
|
|
|
|
|
|
|
|
||||||
|
Stock-based compensation expense by type of award
|
|
|
|
|
|
|
||||||
|
Restricted stock awards
|
|
$
|
178
|
|
|
$
|
140
|
|
|
$
|
144
|
|
|
Stock options
|
|
33
|
|
|
55
|
|
|
71
|
|
|||
|
ESPP
|
|
32
|
|
|
3
|
|
|
—
|
|
|||
|
|
|
$
|
243
|
|
|
$
|
198
|
|
|
$
|
215
|
|
|
For the year ended
|
|
2019
|
|
2018
|
|
2017
|
||||||
|
DRAM
|
|
$
|
15,247
|
|
|
$
|
21,232
|
|
|
$
|
12,963
|
|
|
NAND
(1)
|
|
6,946
|
|
|
7,897
|
|
|
6,585
|
|
|||
|
Other (primarily 3D XPoint memory and NOR)
|
|
1,213
|
|
|
1,262
|
|
|
774
|
|
|||
|
|
|
$
|
23,406
|
|
|
$
|
30,391
|
|
|
$
|
20,322
|
|
|
(1)
|
MCP revenue is reported within NAND.
|
|
As of
|
|
August 29,
2019 |
|
Opening Balance as of August 31, 2018
|
||||
|
Contract liabilities from customer advances
|
|
$
|
61
|
|
|
$
|
235
|
|
|
Other contract liabilities
|
|
69
|
|
|
113
|
|
||
|
|
|
$
|
130
|
|
|
$
|
348
|
|
|
For the year ended
|
|
2019
|
|
2018
|
|
2017
|
||||||
|
(Gain) loss on disposition of property, plant, and equipment
|
|
$
|
43
|
|
|
$
|
(96
|
)
|
|
$
|
(22
|
)
|
|
Restructure and asset impairments
|
|
(29
|
)
|
|
28
|
|
|
18
|
|
|||
|
Other
|
|
35
|
|
|
11
|
|
|
5
|
|
|||
|
|
|
$
|
49
|
|
|
$
|
(57
|
)
|
|
$
|
1
|
|
|
For the year ended
|
|
2019
|
|
2018
|
|
2017
|
||||||
|
Loss on debt prepayments, repurchases, and conversions
|
|
$
|
(396
|
)
|
|
$
|
(385
|
)
|
|
$
|
(100
|
)
|
|
Loss from changes in currency exchange rates
|
|
(9
|
)
|
|
(75
|
)
|
|
(74
|
)
|
|||
|
Gain on remeasurement of previously-held equity interest in Inotera
|
|
—
|
|
|
—
|
|
|
71
|
|
|||
|
Other
|
|
—
|
|
|
(5
|
)
|
|
(9
|
)
|
|||
|
|
|
$
|
(405
|
)
|
|
$
|
(465
|
)
|
|
$
|
(112
|
)
|
|
For the year ended
|
|
2019
|
|
2018
|
|
2017
|
||||||
|
Income (loss) before income taxes, net income (loss) attributable to noncontrolling interests, and equity in net income (loss) of equity method investees
|
|
|
|
|
|
|
||||||
|
U.S.
|
|
$
|
(67
|
)
|
|
$
|
141
|
|
|
$
|
(56
|
)
|
|
Foreign
|
|
7,115
|
|
|
14,166
|
|
|
5,252
|
|
|||
|
|
|
$
|
7,048
|
|
|
$
|
14,307
|
|
|
$
|
5,196
|
|
|
|
|
|
|
|
|
|
||||||
|
Income tax (provision) benefit
|
|
|
|
|
|
|
||||||
|
Current
|
|
|
|
|
|
|
||||||
|
U.S. federal
|
|
$
|
(36
|
)
|
|
$
|
(54
|
)
|
|
$
|
—
|
|
|
State
|
|
(2
|
)
|
|
1
|
|
|
(1
|
)
|
|||
|
Foreign
|
|
(319
|
)
|
|
(374
|
)
|
|
(152
|
)
|
|||
|
|
|
(357
|
)
|
|
(427
|
)
|
|
(153
|
)
|
|||
|
Deferred
|
|
|
|
|
|
|
||||||
|
U.S. federal
|
|
(146
|
)
|
|
232
|
|
|
—
|
|
|||
|
State
|
|
91
|
|
|
101
|
|
|
—
|
|
|||
|
Foreign
|
|
(281
|
)
|
|
(74
|
)
|
|
39
|
|
|||
|
|
|
(336
|
)
|
|
$
|
259
|
|
|
39
|
|
||
|
|
|
|
|
|
|
|
||||||
|
Income tax (provision) benefit
|
|
$
|
(693
|
)
|
|
$
|
(168
|
)
|
|
$
|
(114
|
)
|
|
For the year ended
|
|
2019
|
|
2018
|
|
2017
|
|||||||||||||||
|
U.S. federal income tax (provision) benefit at statutory rate
|
|
$
|
(1,480
|
)
|
|
21.0
|
%
|
|
$
|
(3,677
|
)
|
|
25.7
|
%
|
|
$
|
(1,819
|
)
|
|
35.0
|
%
|
|
Foreign tax rate differential
|
|
993
|
|
|
(14.1
|
)%
|
|
2,606
|
|
|
(18.2
|
)%
|
|
1,600
|
|
|
(30.8
|
)%
|
|||
|
U.S. tax on foreign operations
|
|
(327
|
)
|
|
4.6
|
%
|
|
(20
|
)
|
|
0.1
|
%
|
|
(37
|
)
|
|
0.7
|
%
|
|||
|
Repatriation Tax related to the Tax Act
|
|
(10
|
)
|
|
0.1
|
%
|
|
(1,049
|
)
|
|
7.3
|
%
|
|
—
|
|
|
—
|
%
|
|||
|
Remeasurement of deferred tax assets and liabilities related to the Tax Act
|
|
—
|
|
|
—
|
%
|
|
(179
|
)
|
|
1.3
|
%
|
|
—
|
|
|
—
|
%
|
|||
|
Change in valuation allowance
|
|
(40
|
)
|
|
0.6
|
%
|
|
2,079
|
|
|
(14.5
|
)%
|
|
64
|
|
|
(1.2
|
)%
|
|||
|
State taxes, net of federal benefit
|
|
102
|
|
|
(1.4
|
)%
|
|
(84
|
)
|
|
0.6
|
%
|
|
—
|
|
|
—
|
%
|
|||
|
Research and development tax credits
|
|
118
|
|
|
(1.7
|
)%
|
|
90
|
|
|
(0.6
|
)%
|
|
66
|
|
|
(1.3
|
)%
|
|||
|
Other
|
|
(49
|
)
|
|
0.7
|
%
|
|
66
|
|
|
(0.5
|
)%
|
|
12
|
|
|
(0.2
|
)%
|
|||
|
Income tax (provision) benefit
|
|
$
|
(693
|
)
|
|
9.8
|
%
|
|
$
|
(168
|
)
|
|
1.2
|
%
|
|
$
|
(114
|
)
|
|
2.2
|
%
|
|
As of
|
|
2019
|
|
2018
|
||||
|
Deferred tax assets
|
|
|
|
|
||||
|
Net operating loss and tax credit carryforwards
|
|
$
|
1,045
|
|
|
$
|
1,417
|
|
|
Accrued salaries, wages, and benefits
|
|
122
|
|
|
163
|
|
||
|
Property, plant, and equipment
|
|
80
|
|
|
—
|
|
||
|
Other
|
|
110
|
|
|
115
|
|
||
|
Gross deferred tax assets
|
|
1,357
|
|
|
1,695
|
|
||
|
Less valuation allowance
|
|
(277
|
)
|
|
(228
|
)
|
||
|
Deferred tax assets, net of valuation allowance
|
|
1,080
|
|
|
1,467
|
|
||
|
|
|
|
|
|
||||
|
Deferred tax liabilities
|
|
|
|
|
||||
|
Product and process technology
|
|
(138
|
)
|
|
(62
|
)
|
||
|
Property, plant, and equipment
|
|
—
|
|
|
(173
|
)
|
||
|
Other
|
|
(109
|
)
|
|
(213
|
)
|
||
|
Deferred tax liabilities
|
|
(247
|
)
|
|
(448
|
)
|
||
|
|
|
|
|
|
||||
|
Net deferred tax assets
|
|
$
|
833
|
|
|
$
|
1,019
|
|
|
|
|
|
|
|
||||
|
Reported as
|
|
|
|
|
||||
|
Deferred tax assets
|
|
$
|
837
|
|
|
$
|
1,022
|
|
|
Deferred tax liabilities (included in other noncurrent liabilities)
|
|
(4
|
)
|
|
(3
|
)
|
||
|
Net deferred tax assets
|
|
$
|
833
|
|
|
$
|
1,019
|
|
|
Year of Expiration
|
|
U.S. Federal
|
|
State
|
|
Japan
|
|
Taiwan
|
|
Other Foreign
|
|
Total
|
||||||||||||
|
2020 - 2024
|
|
$
|
—
|
|
|
$
|
48
|
|
|
$
|
969
|
|
|
$
|
309
|
|
|
$
|
4
|
|
|
$
|
1,330
|
|
|
2025 - 2029
|
|
—
|
|
|
404
|
|
|
524
|
|
|
4
|
|
|
12
|
|
|
944
|
|
||||||
|
2030 - 2034
|
|
—
|
|
|
296
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
296
|
|
||||||
|
2035 - 2039
|
|
5
|
|
|
72
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
77
|
|
||||||
|
Indefinite
|
|
—
|
|
|
1
|
|
|
—
|
|
|
241
|
|
|
8
|
|
|
250
|
|
||||||
|
|
|
$
|
5
|
|
|
$
|
821
|
|
|
$
|
1,493
|
|
|
$
|
554
|
|
|
$
|
24
|
|
|
$
|
2,897
|
|
|
Year of Tax Credit Expiration
|
|
U.S. Federal
|
|
State
|
|
Total
|
||||||
|
2020 - 2024
|
|
$
|
—
|
|
|
$
|
55
|
|
|
$
|
55
|
|
|
2025 - 2029
|
|
—
|
|
|
58
|
|
|
58
|
|
|||
|
2030 - 2034
|
|
3
|
|
|
113
|
|
|
116
|
|
|||
|
2035 - 2039
|
|
350
|
|
|
4
|
|
|
354
|
|
|||
|
Indefinite
|
|
—
|
|
|
75
|
|
|
75
|
|
|||
|
|
|
$
|
353
|
|
|
$
|
305
|
|
|
$
|
658
|
|
|
For the year ended
|
|
2019
|
|
2018
|
|
2017
|
||||||
|
Beginning unrecognized tax benefits
|
|
$
|
261
|
|
|
$
|
327
|
|
|
$
|
304
|
|
|
Increases related to tax positions from prior years
|
|
124
|
|
|
—
|
|
|
—
|
|
|||
|
Increases related to tax positions taken in current year
|
|
44
|
|
|
68
|
|
|
15
|
|
|||
|
Decreases related to tax positions from prior years
|
|
(46
|
)
|
|
(126
|
)
|
|
—
|
|
|||
|
Settlements with tax authorities
|
|
—
|
|
|
(8
|
)
|
|
(47
|
)
|
|||
|
Increases due to the Inotera Acquisition
|
|
—
|
|
|
—
|
|
|
54
|
|
|||
|
Other
|
|
—
|
|
|
—
|
|
|
1
|
|
|||
|
Ending unrecognized tax benefits
|
|
$
|
383
|
|
|
$
|
261
|
|
|
$
|
327
|
|
|
For the year ended
|
|
2019
|
|
2018
|
|
2017
|
||||||
|
Net income attributable to Micron – Basic
|
|
$
|
6,313
|
|
|
$
|
14,135
|
|
|
$
|
5,089
|
|
|
Assumed conversion of debt
|
|
(12
|
)
|
|
—
|
|
|
—
|
|
|||
|
Net income attributable to Micron – Diluted
|
|
$
|
6,301
|
|
|
$
|
14,135
|
|
|
$
|
5,089
|
|
|
|
|
|
|
|
|
|
||||||
|
Weighted-average common shares outstanding – Basic
|
|
1,114
|
|
|
1,152
|
|
|
1,089
|
|
|||
|
Dilutive effect of equity plans and convertible notes
|
|
29
|
|
|
77
|
|
|
65
|
|
|||
|
Weighted-average common shares outstanding – Diluted
|
|
1,143
|
|
|
1,229
|
|
|
1,154
|
|
|||
|
|
|
|
|
|
|
|
||||||
|
Earnings per share
|
|
|
|
|
|
|
||||||
|
Basic
|
|
$
|
5.67
|
|
|
$
|
12.27
|
|
|
$
|
4.67
|
|
|
Diluted
|
|
5.51
|
|
|
11.51
|
|
|
4.41
|
|
|||
|
For the year ended
|
|
2019
|
|
2018
|
|
2017
|
|||
|
Equity plans
|
|
8
|
|
|
3
|
|
|
21
|
|
|
Convertible notes
|
|
—
|
|
|
—
|
|
|
26
|
|
|
For the year ended
|
|
2019
|
|
2018
|
|
2017
|
||||||
|
Revenue
|
|
|
|
|
|
|
||||||
|
CNBU
|
|
$
|
9,968
|
|
|
$
|
15,252
|
|
|
$
|
8,624
|
|
|
MBU
|
|
6,403
|
|
|
6,579
|
|
|
4,424
|
|
|||
|
SBU
|
|
3,826
|
|
|
5,022
|
|
|
4,514
|
|
|||
|
EBU
|
|
3,137
|
|
|
3,479
|
|
|
2,695
|
|
|||
|
All Other
|
|
72
|
|
|
59
|
|
|
65
|
|
|||
|
|
|
$
|
23,406
|
|
|
$
|
30,391
|
|
|
$
|
20,322
|
|
|
|
|
|
|
|
|
|
||||||
|
Operating income (loss)
|
|
|
|
|
|
|
||||||
|
CNBU
|
|
$
|
4,645
|
|
|
$
|
9,773
|
|
|
$
|
3,755
|
|
|
MBU
|
|
2,606
|
|
|
3,033
|
|
|
927
|
|
|||
|
SBU
|
|
(386
|
)
|
|
964
|
|
|
552
|
|
|||
|
EBU
|
|
923
|
|
|
1,473
|
|
|
975
|
|
|||
|
All Other
|
|
13
|
|
|
—
|
|
|
23
|
|
|||
|
|
|
7,801
|
|
|
15,243
|
|
|
6,232
|
|
|||
|
|
|
|
|
|
|
|
||||||
|
Unallocated
|
|
|
|
|
|
|
||||||
|
Stock-based compensation
|
|
(243
|
)
|
|
(198
|
)
|
|
(215
|
)
|
|||
|
Employee severance
|
|
(116
|
)
|
|
—
|
|
|
—
|
|
|||
|
Start-up and preproduction costs
|
|
(58
|
)
|
|
—
|
|
|
—
|
|
|||
|
Restructure and asset impairments
|
|
32
|
|
|
(28
|
)
|
|
(18
|
)
|
|||
|
Flow-through of Inotera inventory step up
|
|
—
|
|
|
—
|
|
|
(107
|
)
|
|||
|
Other
|
|
(40
|
)
|
|
(23
|
)
|
|
(24
|
)
|
|||
|
|
|
(425
|
)
|
|
(249
|
)
|
|
(364
|
)
|
|||
|
|
|
|
|
|
|
|
||||||
|
Operating income
|
|
$
|
7,376
|
|
|
$
|
14,994
|
|
|
$
|
5,868
|
|
|
For the year ended
|
|
2019
|
|
2018
|
|
2017
|
||||||
|
CNBU
|
|
$
|
1,833
|
|
|
$
|
1,755
|
|
|
$
|
1,344
|
|
|
MBU
|
|
1,235
|
|
|
1,077
|
|
|
926
|
|
|||
|
SBU
|
|
1,555
|
|
|
1,295
|
|
|
1,083
|
|
|||
|
EBU
|
|
748
|
|
|
603
|
|
|
484
|
|
|||
|
All Other
|
|
27
|
|
|
18
|
|
|
13
|
|
|||
|
Unallocated
|
|
26
|
|
|
11
|
|
|
11
|
|
|||
|
|
|
$
|
5,424
|
|
|
$
|
4,759
|
|
|
$
|
3,861
|
|
|
For the year ended
|
|
2019
|
|
2018
|
|
2017
|
|||
|
Mobile
|
|
25
|
%
|
|
20
|
%
|
|
20
|
%
|
|
Client and graphics
|
|
20
|
%
|
|
25
|
%
|
|
20
|
%
|
|
Enterprise and cloud server
|
|
20
|
%
|
|
25
|
%
|
|
15
|
%
|
|
SSDs and other storage
|
|
15
|
%
|
|
15
|
%
|
|
20
|
%
|
|
Automotive, industrial, and consumer
|
|
15
|
%
|
|
10
|
%
|
|
15
|
%
|
|
For the year ended
|
|
2019
|
|
2018
|
|
2017
|
||||||
|
United States
|
|
$
|
12,451
|
|
|
$
|
17,116
|
|
|
$
|
11,359
|
|
|
Mainland China (excluding Hong Kong)
|
|
3,595
|
|
|
3,607
|
|
|
1,539
|
|
|||
|
Taiwan
|
|
2,703
|
|
|
3,918
|
|
|
2,892
|
|
|||
|
Hong Kong
|
|
1,614
|
|
|
1,761
|
|
|
1,429
|
|
|||
|
Other Asia Pacific
|
|
1,032
|
|
|
1,458
|
|
|
1,078
|
|
|||
|
Japan
|
|
958
|
|
|
1,265
|
|
|
1,042
|
|
|||
|
Other
|
|
1,053
|
|
|
1,266
|
|
|
983
|
|
|||
|
|
|
$
|
23,406
|
|
|
$
|
30,391
|
|
|
$
|
20,322
|
|
|
As of
|
|
2019
|
|
2018
|
||||
|
Taiwan
|
|
$
|
9,397
|
|
|
$
|
7,640
|
|
|
Singapore
|
|
7,986
|
|
|
6,933
|
|
||
|
Japan
|
|
5,202
|
|
|
3,451
|
|
||
|
United States
|
|
5,048
|
|
|
5,113
|
|
||
|
China
|
|
370
|
|
|
398
|
|
||
|
Other
|
|
237
|
|
|
137
|
|
||
|
|
|
$
|
28,240
|
|
|
$
|
23,672
|
|
|
2019
|
|
Fourth Quarter
|
|
Third Quarter
|
|
Second Quarter
|
|
First Quarter
|
||||||||
|
Revenue
|
|
$
|
4,870
|
|
|
$
|
4,788
|
|
|
$
|
5,835
|
|
|
$
|
7,913
|
|
|
Gross margin
|
|
1,395
|
|
|
1,828
|
|
|
2,864
|
|
|
4,615
|
|
||||
|
Operating income
|
|
650
|
|
|
1,010
|
|
|
1,957
|
|
|
3,759
|
|
||||
|
Net income
|
|
586
|
|
|
851
|
|
|
1,625
|
|
|
3,296
|
|
||||
|
Net income attributable to Micron
|
|
561
|
|
|
840
|
|
|
1,619
|
|
|
3,293
|
|
||||
|
|
|
|
|
|
|
|
|
|
||||||||
|
Earnings per share
|
|
|
|
|
|
|
|
|
||||||||
|
Basic
|
|
$
|
0.51
|
|
|
$
|
0.76
|
|
|
$
|
1.45
|
|
|
$
|
2.91
|
|
|
Diluted
|
|
0.49
|
|
|
0.74
|
|
|
1.42
|
|
|
2.81
|
|
||||
|
2018
|
|
Fourth Quarter
|
|
Third Quarter
|
|
Second Quarter
|
|
First Quarter
|
||||||||
|
Revenue
|
|
$
|
8,440
|
|
|
$
|
7,797
|
|
|
$
|
7,351
|
|
|
$
|
6,803
|
|
|
Gross margin
|
|
5,151
|
|
|
4,723
|
|
|
4,270
|
|
|
3,747
|
|
||||
|
Operating income
|
|
4,377
|
|
|
3,953
|
|
|
3,567
|
|
|
3,097
|
|
||||
|
Net income
|
|
4,326
|
|
|
3,823
|
|
|
3,311
|
|
|
2,678
|
|
||||
|
Net income attributable to Micron
|
|
4,325
|
|
|
3,823
|
|
|
3,309
|
|
|
2,678
|
|
||||
|
|
|
|
|
|
|
|
|
|
||||||||
|
Earnings per share
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
|
Basic
|
|
$
|
3.73
|
|
|
$
|
3.30
|
|
|
$
|
2.86
|
|
|
$
|
2.36
|
|
|
Diluted
|
|
3.56
|
|
|
3.10
|
|
|
2.67
|
|
|
2.19
|
|
||||
|
1.
|
Financial Statements: See Index to Consolidated Financial Statements under Item 8.
|
|
2.
|
Financial Statement Schedule:
Schedule II – Valuation and Qualifying Accounts
Certain Financial Statement Schedules have been omitted since they are either not required, not applicable, or the information is otherwise included.
|
|
3.
|
Exhibits.
|
|
|
Balance at
Beginning of
Year
|
|
Charged
(Credited) to
Income Tax
Provision
|
|
Currency
Translation
and Charges
to Other
Accounts
|
|
Balance at
End of
Year
|
||||||||
|
Deferred Tax Asset Valuation Allowance
|
|
|
|
|
|
|
|
|
|
|
|
||||
|
Year ended August 29, 2019
|
$
|
228
|
|
|
$
|
40
|
|
|
$
|
9
|
|
|
$
|
277
|
|
|
Year ended August 30, 2018
|
2,321
|
|
|
(2,079
|
)
|
|
(14
|
)
|
|
228
|
|
||||
|
Year ended August 31, 2017
|
2,107
|
|
|
(64
|
)
|
|
278
|
|
|
2,321
|
|
||||
|
Exhibit Number
|
Description of Exhibit
|
Filed Herewith
|
Form
|
Period Ending
|
Exhibit/ Appendix
|
Filing Date
|
|
2.1*
|
|
8-K/A
|
|
2.1
|
10/31/12
|
|
|
2.2*
|
|
8-K
|
|
2.3
|
10/31/12
|
|
|
2.3*
|
|
8-K
|
|
2.4
|
8/6/13
|
|
|
2.4
|
|
8-K
|
|
2.5
|
8/6/13
|
|
|
2.5
|
|
10-Q
|
3/3/16
|
2.6
|
4/8/16
|
|
|
3.1
|
|
8-K
|
|
99.2
|
1/26/15
|
|
|
3.2
|
|
8-K
|
|
99.2
|
7/1/19
|
|
|
4.1
|
|
8-K
|
|
4.3
|
4/18/12
|
|
|
4.2
|
|
8-K
|
|
4.3
|
4/18/12
|
|
|
4.3
|
|
8-K
|
|
4.3
|
2/12/13
|
|
|
4.4
|
|
8-K
|
|
4.3
|
2/12/13
|
|
|
4.5
|
|
8-K
|
|
4.1
|
7/29/14
|
|
|
4.6
|
|
8-K
|
|
4.1
|
7/29/14
|
|
|
4.7
|
|
8-K
|
|
4.1
|
7/22/16
|
|
|
4.8
|
|
8-K
|
|
4.1
|
2/6/19
|
|
|
4.9
|
|
8-K
|
|
4.2
|
2/6/19
|
|
|
4.10
|
|
8-K
|
|
4.3
|
2/6/19
|
|
|
4.11
|
|
8-K
|
|
4.4
|
2/6/19
|
|
|
4.12
|
|
8-K
|
|
4.5
|
2/6/19
|
|
|
4.13
|
|
8-K
|
|
4.2
|
7/12/19
|
|
|
Exhibit Number
|
Description of Exhibit
|
Filed Herewith
|
Form
|
Period Ending
|
Exhibit/ Appendix
|
Filing Date
|
|
4.14
|
|
8-K
|
|
4.3
|
7/12/19
|
|
|
4.15
|
|
8-K
|
|
4.4
|
7/12/19
|
|
|
10.1
|
|
DEF 14A
|
|
B
|
12/7/17
|
|
|
10.2
|
|
10-K
|
9/1/16
|
10.6
|
10/28/16
|
|
|
10.3
|
|
10-K
|
9/1/16
|
10.7
|
10/28/16
|
|
|
10.4
|
|
10-K
|
9/1/16
|
10.8
|
10/28/16
|
|
|
10.5
|
|
10-K
|
9/1/16
|
10.9
|
10/28/16
|
|
|
10.6
|
|
10-K
|
9/1/16
|
10.10
|
10/28/16
|
|
|
10.7
|
|
10-K
|
9/1/16
|
10.11
|
10/28/16
|
|
|
10.8*
|
|
10-Q
|
11/30/06
|
10.66
|
1/16/07
|
|
|
10.9
|
|
10-Q
|
2/27/14
|
10.3
|
4/7/14
|
|
|
10.10*
|
|
10-Q
|
12/1/05
|
10.155
|
1/10/06
|
|
|
10.11
|
|
8-K
|
|
99.2
|
11/1/07
|
|
|
10.12
|
|
10-Q
|
12/4/08
|
10.70
|
1/13/09
|
|
|
10.13*
|
|
10-Q
|
3/1/12
|
10.104
|
4/9/12
|
|
|
10.14*
|
|
10-Q
|
5/31/12
|
10.108
|
7/9/12
|
|
|
10.15*
|
|
10-Q
|
5/31/12
|
10.109
|
7/9/12
|
|
|
10.16*
|
|
10-Q
|
5/31/12
|
10.110
|
7/9/12
|
|
|
10.17*
|
|
10-Q
|
5/31/12
|
10.111
|
7/9/12
|
|
|
10.18*
|
|
10-Q
|
5/31/12
|
10.112
|
7/9/12
|
|
|
10.19*
|
|
10-Q/A
|
2/28/13
|
10.126
|
8/7/13
|
|
|
10.20*
|
|
10-Q
|
2/28/13
|
10.127
|
4/8/13
|
|
|
Exhibit Number
|
Description of Exhibit
|
Filed Herewith
|
Form
|
Period Ending
|
Exhibit/ Appendix
|
Filing Date
|
|
10.21*
|
|
10-Q/A
|
2/28/13
|
10.128
|
8/7/13
|
|
|
10.22*
|
|
10-Q
|
2/28/13
|
10.129
|
4/8/13
|
|
|
10.23*
|
|
8-K/A
|
|
10.139
|
10/2/13
|
|
|
10.24*
|
|
8-K
|
|
10.140
|
8/6/13
|
|
|
10.25*
|
|
8-K/A
|
|
10.141
|
10/2/13
|
|
|
10.26
|
|
8-K
|
|
10.1
|
2/12/13
|
|
|
10.27*
|
|
10-Q
|
3/2/17
|
10.50
|
3/28/17
|
|
|
10.28*
|
|
10-Q/A
|
3/3/16
|
10.57
|
9/8/16
|
|
|
10.29
|
|
10-Q
|
3/3/16
|
10.59
|
4/8/16
|
|
|
10.30*
|
|
10-Q
|
6/2/16
|
10.61
|
7/6/16
|
|
|
10.31
|
|
10-Q
|
5/31/18
|
10.64
|
6/22/18
|
|
|
10.32
|
|
10-Q
|
6/1/17
|
10.67
|
6/30/17
|
|
|
10.33
|
|
10-Q
|
11/30/17
|
10.70
|
12/20/17
|
|
|
10.34
|
|
10-K
|
8/31/17
|
10.71
|
10/26/17
|
|
|
10.35
|
|
8-K
|
|
99.1
|
11/13/17
|
|
|
10.36
|
|
10-Q
|
11/30/17
|
10.74
|
12/20/17
|
|
|
10.37
|
|
DEF 14A
|
|
A
|
12/7/17
|
|
|
10.38
|
|
10-Q
|
3/1/18
|
10.76
|
3/23/18
|
|
|
10.39
|
|
10-K
|
8/30/18
|
10.68
|
10/15/18
|
|
|
10.40
|
|
10-K
|
8/30/18
|
10.69
|
10/15/18
|
|
|
Exhibit Number
|
Description of Exhibit
|
Filed Herewith
|
Form
|
Period Ending
|
Exhibit/ Appendix
|
Filing Date
|
|
10.41
|
|
10-Q
|
11/29/18
|
10.70
|
12/19/18
|
|
|
10.42
|
X
|
|
|
|
|
|
|
21.1
|
X
|
|
|
|
|
|
|
23.1
|
X
|
|
|
|
|
|
|
31.1
|
X
|
|
|
|
|
|
|
31.2
|
X
|
|
|
|
|
|
|
32.1
|
X
|
|
|
|
|
|
|
32.2
|
X
|
|
|
|
|
|
|
101.INS
|
XBRL Instance Document
|
X
|
|
|
|
|
|
101.SCH
|
XBRL Taxonomy Extension Schema Document
|
X
|
|
|
|
|
|
101.CAL
|
XBRL Taxonomy Extension Calculation Linkbase Document
|
X
|
|
|
|
|
|
101.DEF
|
XBRL Taxonomy Extension Definition Linkbase Document
|
X
|
|
|
|
|
|
101.LAB
|
XBRL Taxonomy Extension Label Linkbase Document
|
X
|
|
|
|
|
|
101.PRE
|
XBRL Taxonomy Extension Presentation Linkbase Document
|
X
|
|
|
|
|
|
|
|
Micron Technology, Inc.
|
|
|
Date
|
October 17, 2019
|
By:
|
/s/ David A. Zinsner
|
|
|
|
|
David A. Zinsner
Senior Vice President and Chief Financial Officer
|
|
|
|
|
(Principal Financial Officer)
|
|
Signature
|
Title
|
Date
|
|
|
|
|
|
/s/ Sanjay Mehrotra
|
President and
|
October 17, 2019
|
|
(Sanjay Mehrotra)
|
Chief Executive Officer and
|
|
|
|
Director
|
|
|
|
(Principal Executive Officer)
|
|
|
|
|
|
|
/s/ David A. Zinsner
|
Senior Vice President and
|
October 17, 2019
|
|
(David A. Zinsner)
|
Chief Financial Officer
|
|
|
|
(Principal Financial Officer)
|
|
|
|
|
|
|
/s/ Paul Marosvari
|
Vice President and
|
October 17, 2019
|
|
(Paul Marosvari)
|
Chief Accounting Officer
|
|
|
|
(Principal Accounting Officer)
|
|
|
|
|
|
|
/s/ Robert L. Bailey
|
Director
|
October 17, 2019
|
|
(Robert L. Bailey)
|
|
|
|
|
|
|
|
/s/ Richard M. Beyer
|
Director
|
October 17, 2019
|
|
(Richard M. Beyer)
|
|
|
|
|
|
|
|
/s/ Patrick J. Byrne
|
Director
|
October 17, 2019
|
|
(Patrick J. Byrne)
|
|
|
|
|
|
|
|
/s/ Steve Gomo
|
Director
|
October 17, 2019
|
|
(Steve Gomo)
|
|
|
|
|
|
|
|
/s/ Mary Pat McCarthy
|
Director
|
October 17, 2019
|
|
(Mary Pat McCarthy)
|
|
|
|
|
|
|
|
/s/ Robert E. Switz
|
Chairman of the Board
|
October 17, 2019
|
|
(Robert E. Switz)
|
Director
|
|
|
|
|
|
|
/s/ MaryAnn Wright
|
Director
|
October 17, 2019
|
|
(MaryAnn Wright)
|
|
|
No information found
* THE VALUE IS THE MARKET VALUE AS OF THE LAST DAY OF THE QUARTER FOR WHICH THE 13F WAS FILED.
| FUND | NUMBER OF SHARES | VALUE ($) | PUT OR CALL |
|---|
| DIRECTORS | AGE | BIO | OTHER DIRECTOR MEMBERSHIPS |
|---|
No information found
Customers
| Customer name | Ticker |
|---|---|
| Pitney Bowes Inc. | PBI |
Price
Yield
| Owner | Position | Direct Shares | Indirect Shares |
|---|